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Background:   The measurement of, and reporting on clinical outcomes, is an integral part of clinical  
 governance but no consensus has been reached about which measures to use and the  
 validity thereof.  
 
Objective:  To compare an administrative predictive model (Hospital Standardised Mortality Ratio  
[HSMR]) with a physiological predictive model (APACHE®IV) to determine the correlation 
in the predicted risk adjusted mortality rates.   
To determine whether stratifying the patients into low (<10%), medium (<50%) or high 
(>80%) risk bands will lead to more accurate comparisons.  
 
Design: Prospective cohort study 
 
Setting: 63 critical care units in 34 private acute care facilities across South Africa 
Methods:  Both HSMR and APACHE®IV are calculated routinely in all participating facilities and  
the research study will use the data generated.  An additional audit process will be 
implemented to determine and ensure the integrity of the data.  
Ethics:  The healthcare facilities have standard processes in place to ensure confidentiality and  
the statistician analysing the data is employed by the healthcare group and bound to a 
confidentiality agreement.  Ethics approval has also been obtained by the University of 


































The healthcare industry, private as well as public, is under increasing pressure to provide proof of  
“quality service” and guaranteed clinical outcomes ͘ The “Deficit Reduction Act of 2005” lead to  
Medicare (United States), since 1 October 2008, not reimbursing hospitals for a number of  
complications or co morbidities that is deemed to be preventable. (1)  South African funders of  
medical aid schemes are placing increasing pressure on private healthcare providers to take  
responsibility for some preventable adverse events that take place in their facilities and carry the  
accompanied financial risk. Ruff et al has stated that “outcomes” and “process re-engineering” are  
critical in the development of a “re-engineered” health sector. (2)  Discovery Health is a private  
health insurer and on the forefront of innovation in managed healthcare.  They have developed a  
number of case-mix tools: “Diagnosis Related Groupings (DRG’s) - for hospital events; an Episode  
Grouper (for multiple ongoing and simultaneous member events); and Adjusted Clinical Groups (a  
system that develops a composite member risk score and promotes population-wide segmentation  
analysis and management)” which is used in negotiating tariffs and contracts(͘2)  The healthcare  
funders have information on all aspects of patient care e.g. radiology, pathology, pharmacy, etc and  
is able to calculate a “cost-per-event” for healthcare encounters ͘  They use the data to extrapolate 
the quality of clinical care, patient outcomes, negotiate tariffs and build networks of service  
providers. (2)  
In the private healthcare institutions, included in the study, administrative data is used as a proxy  
measurement for clinical outcomes as the clinical information available in the files is mostly  
captured by nursing staff and very few doctors’ record clinical findings in the patient folder ͘  
Hospital Standardised Mortality Ratio (HSMR), Re-admissions (patients admitted within 30 days of  
discharge), Extended Length of Hospital Stay (ELOS), Adverse Patient Events and Antimicrobial usage  
is measured and reported on monthly.  HSMR is used as a means of identifying institutions with a  
higher than expected mortality index and thus proxy for possible poor quality of care. Hospital  
management however was mostly opposed to the measure and felt that it didn’t accurately reflect  
the care rendered.  
 
Background and Rationale  
The “International Classification of Diseases (ICD) is the standard diagnostic tool for epidemiology,  
health management and clinical purposes.  This includes the analysis of the general health situation  
of population groups.  It is used to monitor the incidence and prevalence of diseases and other  
health problems”͘ (3) In May 1990 the Forty-third World Health Assembly accepted ICD-10 and WHO  
member states started implementing it since 1994.  Development has already started on the 11th  
revision and it’s expected that this will be finalised by 2015. (3)  ICD-10 coding was implemented as a  
South African diagnostic coding standard on 1 July 2005.  The Medical Schemes Act 131 of 1998,  
Regulation (5) f states that in order to facilitate payment of an account it has to contain an ICD-10  
code related to the episode of healthcare.(4)  The purpose of diagnostic coding standards is to  
translate healthcare conditions and diseases from descriptions to alphanumeric code.  This simplifies  
the process of storing, retrieving and analysis of the information.  As standardised definitions and  
coding rules are used it can also be used to compare outcomes (morbidity and mortality rates)  
globally. (4)  
 
 
4 | P a g e  
8 
 
Current Procedural Terminology (CPT) is a numeric, 5-digit code used to identify the services rendered 
by the practitioners.  In South Africa we are currently using the American Medical Association 
“Physicians’ Current Procedural Terminology” fourth version.  The main section of the CPT body is 
listed as six sections:  
 
   Evaluation/Management 99201-99499 
   Anaesthesia 00100-01999 
   Surgery 10040-69990 
   Radiology 70010-79999 
   Pathology/Laboratory 80048-89398 
   Medicine 90281-99607 
CPT-4 coding is used in the private healthcare facility for billing of surgery and procedures.  South 
African Dental Association (SADA) codes are used for dental procedures.  (5)  
At the private healthcare institution the clinical information in the patient folder is translated into 
ICD-10, CPT-4 and or SADA codes by a case-manager or dedicated clinical coder and recorded on the 
Patient Administrative System (PAS) database where it is stored on the local server and transferred to 
a central server nightly ͘ The information is then “dumped” in the data warehouse on a weekly basis. 
All patient records have at least a primary diagnosis code as this practice is legislated and the codes 
generate a hospital account. (5)  
The training of coders and case managers is done “in-house” by five regional clinical information  
specialists and consists of: “intermediate ICD-10 course (5 days of formal learning), advanced ICD-10  
course (5 days of formal learning) and CPT-4 (5days of formal learning)”͘ The learning material was  
developed in-house and includes training on the use of SADA codes. The candidates write an  
examination one week after completion of the course and a certificate of competence is issued. Staff  
is sometimes trained as “relief” coders and do not use the skill regularly ͘  Training is repeated if  
coding audits show poor results, no standard benchmark exists, with a possible lack of knowledge or  
insight.  Coding quality and accuracy is currently verified by formal bi-annual, on-site audits,  
performed by the regional clinical information specialists on a statistically significant sample of  
hospital folders.  The folders is selected by the in-house statisticians to reflect the acuity and “mix”  
of the patients seen in the hospital e.g. patients admitted to critical care units, day cases, etc. A  
sample of the files audited is then re-audited by the clinical coding specialist, “audit of the auditor”,  
and is presented as a score out of 100. This score is adjusted up or down if any significant  
discrepancy is found.  
 
Measuring quality of care in hospitals is complex as it varies extensively.  ͘ The “Donabedian  
framework” is commonly used and is based upon: “3 quality-of-care dimensions that is structure,  
process and outcome”͘ The three measures are interrelated but outcome measures are more  
commonly used. (6) Hospital Standardised Mortality Ratio (HSMR) is a well known outcome+  
indicator, developed by Jarman in 1999, and widely used in the healthcare industry in countries like  
Canada, the United Kingdom, the United States, Sweden, France and Australia. (6) It is perceived as a  
proxy for quality of care and used to track performance over time with the objective of improvement. 
In the Netherlands HSMR was made public since 2011. (6) Concurrently, there are various concerns 
about the accuracy thereof. (7) HSMR is an adjusted measure, consisting of a ratio  
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of the observed deaths versus expected deaths.  The number of expected deaths is calculated by  
using statistical modelling, based on the case mix and a number of other variables. The reference  
value for HSMR is 100 with values above reflecting potentially poor clinical outcomes and values  
below the opposite. (8)  Statistical models can only adjust for known variables. Important factors in  
the adjustment for the case-mix can be unknown or not taken into account and the case-mix not  
accurately adjusting for differences and this is known as the “case-mix adjustment fallacy”. (8)  
The “constant risk fallacy” occurs when a variable is unevenly distributed amongst different  
populations and risk adjusting for the average effect can underestimate it in one group and  
overestimate it in another. (8) The number of clinical codes per hospital account, “coding depth” and 
coding accuracy, can also add to this bias. (9)  HSMR has a “low signal (preventable deaths) to noise 
(unavoidable deaths) ratio” as in most hospitals the number of preventable deaths are so low that 
changes in the small number will not significantly affect the entire mortality index.  Areas of poor 
quality are often isolated in specific areas in a hospital and measuring a global standardised  
mortality ratio (SMR) will not identify the areas of concern.(10)  
In investigating a false high HSMR limited resources is wasted, institutions stigmatised and faith in  
data is lost.  Conversely a false low HSMR diverts the attention from a real concern and can lead to  
false reassurance. (11)  In South Africa mortality rates are not made public and it is measured in  
different ways by the different role players in the industry.  In the public sector crude mortality rates  
or mortality per 1000 patient days is used. (12) The private healthcare industry also varies in their  
manner of measuring mortality rates with crude mortality rates and HSMR used by the 3 largest  
private healthcare groups. (11)  
Acute Physiology Age Chronic Health Evaluation (APACHE) IV is a proprietary prognostic model that  
has been developed to predict mortality rates and compare patient outcomes across different  
critical care units. APACHE was originally developed by Knaus and his colleagues in 1981 and the  
intent was to classify “groups” of patients according to severity of illness.  The original intent was  
never to use it for individual patients. The APACHE model was refined over the time period with  
APACHE III being developed in 1991 and updated in1998.  This was necessitated by discrepancies  
between predicted and clinical outcomes. The third version was remodelled to APACHE IV, recently  
incorporating different predictor variables, refining statistical calculations but keeping the  
physiological variables and weights the same. (14) Clinical data (measuring the “worst” physical  
parameters) is collected over the first 24 hour time period after admission to the critical care unit  
and used to determine an “APA CHE” severity score and a standardised predicted mortality ratio ͘ It 
is crucial to collect accurate data and use standardised definitions.  
 
Vincent, et al. have shown that there are various limitations to the use of severity scoring in  
prognostication, e.g. data input (wide inter- as well as intra-observer variation), geographical  
location (variation in different population) and lead-time bias (early resuscitation in the emergency  
department may lead to more “normal” vital signs being recorded)͘ (13) Only a small percentage of  
critical care units utilise the prognostic scoring models and this may lead to bias as it may be units  
using evidence based protocols and delivering a high quality of care that choose to implement such a  
system ͘Low risk patients can “dilute” the SMR and “hide” a high index ͘  Illness severity may thus be 
a confounder and stratifying the SMR into low (<10%), medium (<50%) or high risk (>80%) bands  
may eliminate part of this bias. (15)  
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Patient administrative data, whether a critical care fee was rendered on the account, is used to  
identify patients that may be eligible for inclusion onto the APACHE IV database. The “level of care” 
(LOC) is billed as “Specialised Critical Care”, “Intensive Care” or “High Care” according to a score  
obtained from the “Clinical Criteria for Specialised Units” document ͘  This document is unique to this 
private healthcare group and records the patient specific clinical information and determines LOC 
classification on the severity of illness and the treatment rendered. (Addendum A).  
 
Research Question  
Is there a difference in the risk adjusted mortality rate when calculated using administrative data  
(HSMR) compared to a physiological predictive model (APACHE IV®) in adult patients admitted to  
critical care units over a 6 month time period in a private healthcare group in South Africa?  
 
Aim & Objectives  
Aim:  
   To determine whether there is any conformity between the HSMR and SMR (physiologic  
 predictive model) in critically ill adult patients in a private healthcare group in Southern  
 Africa.  
   To ascertain whether stratifying the patients according to illness severity leads to a more  




   Compare the HSMR with the SMR (APACHE IV)  
   Compare the HSMR with the SMR (APACHE IV) in patients with a low (10% or less), medium  
 (50% or less) or high (80% or more) predicted mortality  
 
Methodology  
Study design  
A cross sectional  study will be performed.  
Study setting and population  
The study will be conducted amongst adult patients admitted to critical care units (intensive care  
and high care units) in all eligible hospitals of a private healthcare group, Mediclinic, in South Africa  
(see Addendum B). The Mediclinic group has 49 hospitals in South Africa of which 40 renders 
intensive care.  There are 68 intensive care units in these 40 hospitals.  The geographical spread of 
the hospitals is balanced across most of South Africa  
and this will aid in improving the external validity of the study. All patients eligible for inclusion on  
the APACHE IV database will form part of the cohort.  The following patients will be excluded as per  
APACHE IV database rules:  patients younger than 16 years; burns patients; patients admitted with  
chest pain in order to rule out acute myocardial infarction and patients with a critical care unit stay  
of less than 4hours.  Patients receiving specialised care in a general ward due to bed constraints will  
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Data collection and management  
APACHE IV®  
APACHE IV data will be collected manually on a pre-printed document containing all the database  
fields. (Addendum C)  The midpoints of the physiological parameters are indicated on this document,  
and this aids in ease of completion and accuracy of data.  The data is collected by using varied  
methods in the various critical care units.  In the majority of units the data is collected by a  
designated person (usually the unit manager) as part of their daily task, in other units the nursing  
staff member caring for the patient completes the document and a few hospitals have a dedicated  
data collector. The data is routinely collected as part of the daily tasks.  The data is then entered into  
an electronic database (usually by an administrative person) and is “dumped” into a data warehouse  
from where it is analysed. The documents are completed on discharge from the unit or after 24  
hours from admission to the critical care unit has elapsed but some fields (discharge from hospital - 
date and time) will only be completed at a later stage.  This information is not used in the calculation  
of the SMR and will not affect the data. The hospitals are currently upgrading the database from  
APACHE III to APACHE IV and all the relevant role-players have been retrained.  
 
APACHE IV® Audit  
A comprehensive audit program will accompany the new upgrade and will be done as part of the 
normal routine. This will help to gauge the quality of the data collected. The APACHE IV® Score on these 
patients, randomly selected for auditing, will be completed by a trained auditor, unit manager or 
nursing manager, and the SMR compared. The audits will be conducted monthly in order to  
detect and rectify errors early and ensure the validity of the data ͘  an “ audit of the auditor” will be 
conducted on a statistically representative, random sample, selected at the end of the data  
collection time period. The SMR will be compared to determine the degree of correlation and at least 
80% correlation is required. In the event of incomplete data or illegible entries the patient  
documentation will be consulted to gather the correct information.  
Data Analysis - HSMR  
Statistical methodology was developed by the organisation to adjust mortality rates for patient level  
risk factors and death was “treated as a binary response variable and used a logistic regression  
model to measure the relation with patient risk variables in order to adjust for case-mix differences. 
The Mediclinic case-mix methodology was designed and developed by Mr Jannie van Schalkwyk. (16) 
The outcome is an expected value per admission reflecting the probability that the admission will  
result in death”. (Addendum D) The variables taken into account are primary diagnosis, secondary  
diagnosis, age, gender, co morbidities, treating speciality and body-mass index.  The archiving  
system is well controlled and files are seldom lost but in the event that this may happen the patient  
(and the corresponding APACHE IV entry) will be excluded from the cohort. A comparison will be  
made to ensure that patients are included in both the HSMR and the APACHE IV calculations. The  
analysis will be made from the available data in the warehouse and will be analysed by hypothesis  
testing. The electronic data as well as the completed forms with the data fields are part of the  
routine data and are handled according to standard business practices.  
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The approval of the research proposal will take an estimated 2-3 months and as the researcher will  
not be applying for external funding no additional time will be required. The data will be collected 
over a 6 months time period and data collection will start on 1 Jan 2014 and continue until 30 Jun 
2014 or as soon as possible thereafter. The preliminary statistical modelling will start before all data is 
gathered and will be updated with the final information.  The aim is to complete the study no later 
than the end of July 2014. This does leave only a limited time for the completion of the article but 






October 2013 to March 2014 
Item Description Unit Cost Number of 
units 
Total cost 
Consumables     
APACHE IV® Score Form to capture 
information 
R0.67 50 000 R33 500 
Office supplies Pens, etc R2.45 100 R245 
Research travel     
Travel Travel to sites R4.50/km 600km R2 700 
Minor research 
equipment 
    
Database Development of an 
Microsoft Access 





Personnel     
Statistician Currently employed by 
private healthcare 
group and services 
included in daily work 
program 
NIL  NIL 
Research 
assistants 
Auditing data entered 
on the APACHE® Score 
form 
R500/session 5 sessions R2500 
Sundries Editing, printing, 
binding, etc 
  R2 000 
Total    R40 945 
Note:  
The cost marked in “bold” is incorporated in the operational costs of the company and will not apply  
to the researcher. The statisticians are employed by the healthcare group and conducting research is  
an integral part of their daily output. The total cost to the researcher is R7 200 and will be carried by  
the researcher.  
 
 






Strengths and Limitations  
The private healthcare institute has a well functioning clinical information department and uses  
information to monitor patient outcomes and quality of care.  APACHE® is well known and the  
institution has been using APACHE III® for a number of years.  A large number of patients (between  
40 000 - 50 000) are captured on the database yearly and this will add to the external validity of the 
study. A number of dedicated, highly skilled and experienced statisticians is part of the team and 
actively evaluates data gathered and monitor patient outcomes.  Clinical information e.g. coding, etc 
is audited regularly and comprehensive training done to eliminate deficiencies identified.  
The APACHE IV data that is gathered is highly dependent on the knowledge, insight and skill of the  
person gathering and entering the data into the database.  The task is often delegated to a junior  
person or data even entered before the 24 hour time period has elapsed.  The migration from  
APACHE III to IV is accompanied by a comprehensive retraining program and the assignment of  
individuals accountable for data accuracy.  This should mitigate this risk. The company does as yet  
not have 100% compliance on the APACHE IV database. If patients are selectively excluded from the  
database this could lead to bias. However, compliance is generally above 90% and is constantly  
monitored. The unit manager of the critical care unit is responsible for the accuracy of the data and  
compliance.  At present a monthly compliance report is distributed to each unit but with the  
development of APACHE IV integration with the patient administrative system is being developed.  
The information on the patient administrative system will be incorporated in the database and  
eligible patients listed.  This integration will make central monitoring of compliance feasible.  A  
hospital with a compliance of less than 90% will be instructed to investigate and add the patients  
that were not included. The use of patient administrative data to determine if a patient qualifies for  
the   P  CHE IV database may lead to inaccurate in/exclusions ͘  The use of a “criteria score” (in-house  
checklist) will help to mitigate this risk.  
ICD-10 coding is used to translate clinical data (from a document completed in by nursing staff) into  
coded form and diagnosis related groupings (DRG’s)͘  The transfer of information may be incomplete  
or inaccurate as no doctors notes are kept in the patient file; the nursing staff may not complete the  
document correctly or comprehensively; or the coder may not code all the information or use  
inaccurate codes or sequencing. Historically palliative care patients have been excluded from the  
HSMR calculation. In this model these patients are not excluded as an ICD-10 code for palliative care  
is not rendered.  This is partly due to the confusion as to the appropriate definition and the  
reimbursement model of the private healthcare funders. The inclusion of patients admitted for  
palliative care into the HSMR calculation may lead to a value that is higher than the true value and  
may thus not be comparable to other HSMR models. The identification of patients admitted for  
“palliative” or “end-of-life” care is currently not possible with the information at hand ͘  
(7) The HSMR looks at all codes on an account (regardless of sequencing), identifies the one with the  
highest weight and incrementally add weights for the other codes according to a predetermined  
algorithm.  This minimises the effect of incorrect sequencing of the codes. Bi-annual audits measure  
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Ethical considerations  
Ethical approval has been received from the institution and is included (see Addendum E). Ethical  
approval had been granted by the corporate in-house “Research Committee” at the head office of  
the institution and is applicable to all hospitals.  There is no need to obtain approval from all hospital  
managers individually. All patient information is treated as confidential and although individual  
patients will be identified in the gathering of data, all the staff involved in the collecting and analysis  
of data is currently employed by the company and are bound by a confidentiality agreement.  The  
final datasets for the analysis will be analysed by the resident statistician and no raw data with  
patient identifiers published or made available as part of the outcome of the research project.  If the  
need arises to disseminate individual patient information to a wider audience all patient identifiers  
will be removed.  
 
Relevance  
The care of patients in critical care units contribute significantly to healthcare costs.  In the public  
sector the numbers of critical care beds are limited and patients often denied critical care due to a  
shortage of resources.  In the private sector there are more beds available but healthcare funders  
are lobbying for stricter admission criteria to critical care units as it is a large “cost driver” in their  
industry.  The imminent National Health Insurance (NHI) plan, with the government contemplating  
purchasing services from the private sector, will also put pressure on the private sector to provide  
proof of clinical outcomes. It is important to have reliable, well understood, measures of patient  
outcome and the proposed study will help clarify the correlation between current outcome 
measures as utilised in a South African context.  
 
Data Dissemination Plan  
The results of the study will be shared externally as well as internally in the company 
Internal: 
 Presentations to the executive committee as well as the operational committee 
 Presentation to the clinical governance committee 
 Presentations to the regional clinical governance structures for further dissemination to the 
front line stakeholders at hospital 
External: 
 Printed media 
o poster presentation at conference 
o submission of the article to a peer reviewed subject specific journal 








o submission of the article to a peer reviewed journal on the world wide web (if not 
published in a printed format by another journal) 
o discussion of the results on discipline specific blogs 
 Personal 
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The purpose of the Clinical Criteria for Specialised Units form is to determine the correct level of care for a specific patient, according to 
the patient‟s condition.  
It also serves as a tool to obtain accurate coding information.  
The correct level of care and the coding information is used in the case management process in the hospital.  
 
Scope  
This form is completed by the CCU nursing staff and the information gathered is used by the Case Coordinator in the hospital, for 
updating clinical information and for negotiations with medical funds.  
 
Background  
Previously, level of care was determined on the grounds of the amount of nursing input required for a patient.  This method proved  
inaccurate and it was decided that the patient‟s condition would serve as a better indicator as to what level of care a patient  
requires.  
 
About the Form  
In this document the form and its content will be described in general.  Specific keys are used to guide the user through the 
interpretation of the form.  
 
Important  
The criteria are not used on patients in normal wards to determine if they should be send to a specialised unit.  Only after the 
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Sections on the form  
The form is divided into the following sections/tables (Each of these will be discussed separately later in this document):  
 Comorbidities  
LOC (Level of Care) Movement (date and time) 
Respiratory System indicators  
Cardio Vascular System indicators  
Neurological System indicators  
Renal System indicators  
Other  
Medication IVI  
Laboratory Imbalances  
Monitoring/Invasive lines  
Emergency Procedures  
IVI Medication with **  
Additional Notes  
For how many days does the form provide?  
The form can be used for a period of seven (7) days per patient, after which a new form must be completed.  Date columns are 
provided for each section of the form.  
As always, the previous days‟ information is indicated on today‟s date, and the worst scenario of the last 24 hours is indicated on the  
form.  
 
What is the standard method of ticking off the indicators/conditions?  
A normal tick (  ) is placed next to every indicator/condition the patient conforms to for that specific day.  
 
What if the patient has a condition that does not appear on the form?  
With the exception of the Comorbidities columns where extra lines are provided for additional entries, the rest of the sections were 
carefully designed to only include those conditions that would have an effect on the level of care.  
Note that diagnosis was deliberately excluded, since it‟s not an accurate indication of the required level of care.  
 
How do I interpret the keys?  
The keys used on the form are *, ** and ***.  These keys can be found next to specific indicators/conditions and indicate whether 
the patient should be in HIC, CCU or SICU.  Some conditions do not have any key next to it.  Besides the keys itself, the number of 
ticks also serves as an indication of what level of care the patient should occupy.  
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Sections on the Form  
Each section will be discussed separately.  
Only the sections and the indicators that need some discussion will be elaborated on with regards to definitions and circumstances.  
 
Comorbidities  
The 15 most frequently reported comorbidities (according to Mediclinic coding statistics) were listed here.  Additional lines were 
added to provide for extra comorbidities to be listed if necessary.  
 
Comorbidity Description 
Hyperlipidaemia Hyperlipidaemia refers to high blood cholesterol or high blood triglycerides 
Hypercholesterolaemia Hypercholesterolemia refers to high blood cholesterol 
 
 
Patient Status  
In this section we indicate the patient‟s level of care movement by completing the dates and times at which a patient moved into 
and out of a specific unit.  This section should be completed extremely accurately.  
Provision is also made for indicating the date and time periods when a patient was ventilated.  
This information can be used to check whether or not the patient must still be in a specific unit.  
 
Other Important Info  
Additional lines have been provided to include information unrelated to comorbidities, but which has clinical relevance. Examples 
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Respiratory System  
Please note the following indicators/conditions in this section:  
 
Indicator Description 
Mechanically ventilated with FiO₂ Indicates that this patient is in a type 2, 3 or 4 respiratory failure according to the P/F ratio 
> .6** >200. 
NPPV** 
Non-Invasive Positive Pressure 
Ventilation 
NPPV is the delivery of mechanically assisted or generated breaths without placement of an  
artificial airway.  Both CPAP and BiPAP are considered as NPPV. Significant percentages of 
patient who receive this modality are acutely ill or have severe underlying disease. The patient 
does not have to be continuously ventilated non-invasively; it can just be for short periods at a 
time when not coping without ventilatory support.  
Extubated < 24 hrs **  Patient should be in CCU for up to 24 hours post extubation.  Not all extubations are  
successful, and the patient must be monitored for up to 24 hrs for possible re-intubation  
Intubated but not ventilated **  This patient has an endotracheal tube in place, but is not ventilated.  This is often to maintain  
an open airway and help reduce the risk of aspiration.  The patient will require suctioning and  
close monitoring to prevent complications  
Oxygen >40% *  Oxygen therapy per mask greater than 40% or oxygen therapy via nasal cannula (> 5 LPM)  
Saturation < 90% on O₂  > 40% * Indicative of hypoxia despite oxygen therapy and may indicate impending respiratory failure. 
Respiratory acidosis * This is going to require PN interpretation. 
A respiratory acidosis is a pCO2 > 6.1 KPa (irrespective of compensation).  It indicates 
decreased gas exchange  
Respiratory alkalosis * This is going to require PN interpretation. 
A respiratory alkalosis is a pCO2 < 4.6 KPa.  There are multiple causes and often it is a 
compensatory response to metabolic acidosis  
Respiratory rate > 30 bpm*  There are increased oxygen demands and the respiratory rate increases in order to meet this  
demand.  It is indicative of underlying problems and the patient requires close monitoring  
(HICU at least)  
Bronchospasm / Stridor*  These are symptoms of airway obstruction.  Patients are at risk for impending respiratory  
failure  
< 2 hourly nebulisations This is applicable to patients in acute bronchospasm (usually an acute asthma attack) 
< 2 hourly suctioning  When the patient is being suctioned more frequently than 2 hourly.  This is mostly applicable  
to a non-intubated patient who has difficulty maintaining their airway.  This is not suctioning  
of the mouth but rather oro/naso-pharyngeal suctioning to clear secretions and keep the  
airway patent  
Tracheostomy  Note the difference between a Tracheostomy in this section versus a Tracheostomy in the  
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Cardio Vascular System  
Please note the following indicators/conditions in this section:  
 
Indicator Description 
Cardiac arrest within the 1st 24 hours**  If the patient had cardiac arrest, the patient should be in CCU for at least the 1st 24  
hours.  
Sternotomy within 24 hours *** This indicator refers to any heart and lung surgery viewed as „open heart‟ surgery. 
Acute MI < 24 hours with + Trop I/T**  The cardiac markers Troponin T or I are positive indicative of a myocardial infarction,  
irrespective of whether the patient has had an ST-elevation myocardial infarction  
(STEMI) or a non-ST elevation myocardial infarction (NSTEMI).  
Angina *  Angina is classified as stable or unstable.  Unstable angina is chest pain at rest, and  
indicates partial clot formation in a coronary artery causing decreased blood supply to  
the heart muscle.  This decreased blood supply results in „chest pain‟ as a symptom.  
PTCA** / Stent ** < 12 hrs  The patient status is CC due to the nature of the procedure and / or the presence of a  
foreign body.  Percutaneous coronary intervention (PCI) includes balloon angioplasty 
with or without placement of a stent.  A PTCA is invasive enough to warrant CC  
monitoring.  Potential complications include thrombosis and haemorrhage  
Acute Dysrhythmia* Please note that this include ALL ACUTE Dysrhythmias. 
CHRONIC Dysrhythmia is NOT INCLUDED unless a Chronic Dysrhythmia becomes ACUTE. 













Temporary pacemaker-dependent ** 
Note on the difference between the cardioversion indicated in this section, and the 
Cardioversion indicated under Emergency Procedures of which the latter will require CC. 
It is most commonly done for atrial fibrillation, atrial flutter and ventricular tachycardia 
(with a pulse).  Elective cardioversion is electrical cardioversion (also known as direct - 
current or DC cardioversion). 
A dysrhythmia can also be chemically cardioverted (for example with Amiodarone). 
Elective cardioversion is a procedure whereby a synchronized electrical current (shock) is 
delivered through the chest wall to the heart through pads or paddles that are applied to 
the skin of the chest and/or back.  The purpose of the cardioversion is to interrupt the 
abnormal electrical circuit(s) in the heart and to restore a normal heartbeat. 
This is going to require the PN interpretation. 
The temporary pacemaker is external and prone to the development of problems.  This is 
usually only a temporary measure until the underlying problem is resolved or a PPM is 
inserted.  The patient must be PM dependent i.e. they do not have an adequate cardiac 
output without the PM.  
Perm. Pacemaker - post insertion 12 -24 Note that the patient status is High Care following the insertion of a PM.  This is 
hrs * necessary for monitoring of potentially life threatening complications, which include the 
development of a pneumothorax, dysrhythmias and haemorrhage. 
Vasopressor/Positive Inotrope Note on the fact that the patient must be TOTALLY DEPENDENT.  This is the indication for 
dependent ** cardiac failure.  The patient can be dependent on vasopressors or positive inotropes to 
maintain an adequate cardiac output (see list of drugs on the last page of the last page of the 
clinical criteria document).  
Vascular Stent < 12 hrs **  ANY other vascular stent falls under this category.  This would include coronary, aortic,  
carotid and cerebral stents.  Patient requires close monitoring because of the possibility of 
developing acute thrombosis or haemorrhage which would be life threatening.  
Hypovolaemia *  This is going to require the PN interpretation.  
A dramatic reduction in circulating volume as a result of the patient‟s underlying 
condition.  Symptoms include an elevated pulse rate, diminished blood pressure and 
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 signs of decreased perfusion (poor capillary refill, weak peripheral pulses) 
Tachycardia Pulse rate > 100 bpm (in adults) 
Bradycardia Pulse rate < 60 bpm (in adults) 




Neurological System  
Please note the following indicators/conditions in this section:  
 
Indicator Description 
Glascow coma scale < 8** Patient usually not able to maintain or protect their own airway 
Gloscow coma scale 9 - 12* Patient can usually protect their own airway, but needs constant monitoring 
Glascow coma scale 13 - 14 Patient usually just confused / disorientated 
Raised intracranial pressure* According to the Monro-Kellie Hypothesis, the cranial compartment is incompressible  
and the volume inside the cranium is fixed.  The cranium and its constituents (blood, CSF  
& brain) create a state of equilibrium.  If there is any increase in volume in one of the 
cranial constituents, it must be compensated by a decrease in volume of another. 
Normal ICP is 0-15mmHg.  An ICP > 20mmHg can crush brain tissue, shift brain 
structures, contribute to hydrocephalus, cause the brain to herniated and restrict blood  
supply to the brain.  Following a cardiac arrest, a patient can have a resultant hypoxic  
brain injury.  The hypoxic injury results in cerebral vasogenic oedema and is likely to 
result in raised intracranial pressure.  
Ventricular drain **  An intraventricular drain can be inserted into one of the lateral ventricles for diagnostic  
or intracranial pressure relief purposes.  Once placed, the catheter can be connected to a  
transducer for continuous pressure monitoring or to an external collection system for  
drainage.  
Polyuria  Defined as a urine output > 3L/day.  Needs to be considered if the urine output >  
200ml/hr for 2 consecutive hours.  The clinical history is very important to correlate this as a 
true sign.  This is going to require the PN interpretation.  
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Renal System  
Please note the following indicators/conditions in this section:  
The first 3 indicators are based on the RIFLE criteria (Journal of Intensive Care Medicine 22(4); 2007) for acute renal dysfunction (ARD). 
The Rifle classification defines 3 grades of increasing severity of ARD as Risk (R), Injury (I) and Failure (F). The MOST severecriteria is the 
one that should be selected - i.e. if the serum creatinine is 2 X baseline, but the urine output was < 0.5ml/kg/hr X 6hrs (and not 12hrs), 




Serum Creatinine  1.5 X baseline  OR Indicates Risk (R) of renal failure according to the RIFLE criteria (see above). 
Urine output < 0.5ml/kg/hr X 6hrs * 
Serum Creatinine  2 X baseline  OR Indicates Injury (I) to the kidneys according to the RIFLE criteria and patient is at high risk 
Urine output < 0.5ml/kg/hr X 12hrs * for the development of acute renal failure. 
 
Serum Creatinine 3 X baseline  OR Indicates Renal Failure (F) 
Urine output < 0.3ml/kg/hr X 24hrs 
ORAnuria  X 12 hrs **  
Acute renal dialysis **  This refers to continuous or intermittent routine cycles of hemodialysis, irrespective of  
mode (CVVH/CVVHD/CVVHDF). This indicator is not applicable to a patient with  
longstanding chronic renal failure receiving routine intermittent hemodialysis.  
Chronic Renal Failure *  It is difficult distinguishing between persistent acute renal failure and end-stage kidney  





Please note the following indicators/conditions in this section:  
 
Indicator Description 
Major Blood Transfusion**  Major blood transfusion is defined as replacement of the total blood volume within 24  
hours.  The formula is found on the last page of the form.  
Major blood transfusion includes all blood products. 
Autotransfusion* Patient receiving autotransfusion should at least be in HICU, due to high risk. 
Post-operative monitoring* 24 - 48 Note that there is no provision made for ECG monitor, because this is a standard 
hours procedure.  This indicator is for patients that require more intense post operative 
monitoring than provided by wards.  E.g. Knee Replacement. 
Cont. Invasive/Non-invasive monitoring Due to the difficulty defining the term Hemodynamic Instability, this indicator basically 
> 4hrs every 15-30 minutes** replace this term.  The indicator implies that the patient is unstable and would include 
Hemodynamic Unstable patients.  This does not include Post-operative monitoring (as 
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Medication IVI  
Note that the IVI Medication Key at the back of the form serves as a guideline as to which types of medication falls within a specific 
indicator.  This is ONLY applicable to IVI Medication.  Medication indicated with ** are CCU drugs and the patients status remains 
CCU for up to 6 hours post discontinuation of these drugs.  
Please note the following indicators/conditions in this section:  
 
Indicator Description 
Positive inotropic support **  Inotropic drugs increase the contractility of the heart and are often required in cardiac  
failure, septic shock or post surgery.  The list of drugs is named in the table of  
intravenous medication.  
 
 
Vasopressors **  Vasopressors increase the systemic vascular resistance and are used in conditions where  
there is vasodilatation and vasoconstriction is required to improve the blood pressure. 
The use of small amounts of adrenaline in an epidural infusion does not count as  
„Vasopressors‟ as the effect is localised.  
Insulin*  It is recommended that critically ill patients have their blood glucose narrowly controlled  
to improve outcomes (the margin varies depending on disease).  Blood glucose is 
elevated as part of the stress response.  
Sedation**  Drugs that have the ability to suppress a patients breathing and ability to protect their  
own airway.  
TPN  It is extremely important that case management is informed when TPN is administrated,  
in order for accounts to be changed accordingly.  
Examples of TPN include; Isotec, Intralipid and Vamin. 
Opioid*  Refers only to opioid analgesia (not all intravenous analgesia, e.g. Perfalgan).  The route  
of administration can be as patient-controlled analgesia (PCA), via an epidural catheter or 
intravenously (whether intermittently or continuously) or intramuscularly. Opioids can 
cause opioid-induced sedation and respiratory depression.  
Precedex®* See addendum A for MCSA Policy regarding administration of this drug. 
Abnormal high levels of therapeutic This refers to abnormally high drug levels of medication administered for therapeutic 
medication ** reasons - examples include high drug levels of digoxin or amikacin.  This does not refer 




Laboratory Imbalances  
Please note the following indicators/conditions in this section:  
 
Indicator Description 
Positive DIC screen **  This indicates that the patient is in Haematology failure.  DIC screen includes INR, aPTT,  
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Monitoring / Invasive Lines  
Please note the following indicators/conditions in this section:  
 
Indicator Description 
ICP monitor 1st 24 hours*** For the first 24 hours post insertion the patient is in SICU. 
ICP monitor > 24 hours** After the 1st 24 hours, as long as the ICP monitor is in situ, the patient is in ICU. 
Central venous O₂ saturation *  A normal SVcvO₂ is > 70%.  The value is decreased if there is decreased tissue perfusion,  




Emergency Procedures  




IV Medication with **  
Please note that IVI medication marked with ** are indicated as CCU patients.  The patient remains CCU for up to 6 hrs post 




Additional Diagnostic Information  
Any comment that could add to the background of the patient‟s clinical condition can be indicated in this section.  Be sure to indicate 
the date of the comment.  This section is also used if the required LOC could not be explained throughout the criteria.  It is also  
suitable for indicating a planned procedure, planned discharge and any other relevant information not mentioned in the rest of the 
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Completing the Form  
The method/procedure of completing the form will be explained by means of a scenario.  
Scenario:  A patient was transferred to a specialised unit the previous day, e.g. 6 July 2011 at 11:30  
Today, 7 July 2011, you have to complete the Clinical Criteria for Specialised Units form according the patient‟s condition the last 24  
hours.  
 
Step Action Note 
1 Stick a patient sticker onto the form in the space provided (top left-hand 
corner) 
2 Write the diagnosis of the patient onto the form in the space provided (top 
right-hand corner) 
3 Write today‟s date (e.g. 7 July 2010) in the first date column of the first 
section you want to complete. 
4 Read through all the indicators/condition in that specific section and tick off 
that which is relevant to the patient. 
5 Repeat steps 3 and 4 for all the applicable sections. 
6 After ticking off all the applicable conditions, check the keys for each E.g.  If a box (indicator/condition) 
marked 
indicator/condition (i.e. *, **, ***) and interpret it according to the key-table with *** is ticked off, the patient should 
on the form. be in SICU,  if 3 ticks were made in 
boxes 
that are not marked with *,** or ***, the 
patient should be in HIC, etc. 7 Complete / update the Patient Status section. 
8 The completed form must be sent to the Unit Manager. 
9 After the form is evaluated and found to be accurate and complete, it must 
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Addendum B    Critical Care Units entering patients on APACHE IV  
 database  
Central Region  
   MC Bloemfontein  
   MC Hoogland  
   MC Howick  
   MC Kimberley  
   MC Newcastle  
   MC Pietermaritzburg 
   MC Victoria  
   MC Welkom  
Northern Region  
 
   MC Emfuleni  
   MC Highveld  
   MC Morningside  
   MC Nelspruit  
   MC Potchefstroom 
   MC Sandton  
   MC Vereeniging  
   Wits Donald Gordon Medical Centre  
Peninsula Region  
 
   MC Cape Gate  
   MC Cape Town  
   MC Constantiaberg  
   MC Durbanville  
   MC Louis Leipoldt  
   MC Milnerton  
   MC Panorama  
   MC Upington  
 
Tshwane Region  
 
   MC Brits  
   MC Heart Hospital 
   MC Kloof  
   MC Legae  
   MC Limpopo  
   MC Medforum  
   MC Muelmed  
   MC Thabazimbi  
   MC Tzaneen  





--- -------- -----------' 
Primary Di<~gnosis: 
Second<lry Diagnosis: ------ ---------- -
Surgical D1agnos1s: 
Secondary Diagnosis. ---------------
CLINICAL CRITERIA FOR 
SPECIALISED UNITS 
REPORT ON WORST CASE SCENARIO IN LAST 24 HOURS AUTHORISATION (I hereby certify that mentioned must be admitted to) 
Signature 
PATIENT STATUS level of Care Level of Care Movement 
I· .. Specialised Critical Care Date Time Date ·nrne 
Specialised Critical Care 
Three {3) or more organ failures From 
.. To : 
Critical Care 
Seven (7) Ticks without ... or •·• Ventilator: From : : 
To : 
High Care 
j Thr~e (3) Ticks without •·• or •• or • 
COMORBIDITIES Critical Care Dale Time Date Time 





Unstable Angina I Obesity BMI> 30 To : 
Hypertension I Chronic Arterial Fibrilal!on/Fiutter Ventilator· From 
Hyperthlrrodisrn I Epilepsy To : 
Hypercholesterolaemi<J 1 Diabetes (Insulin dependent) High Care Date Time Date Time 
I 
Diabetes (Non-lnslJI:n depundcnt) J Fro Ill 
Chronic Renal F.:rilure I To i 
Congestive He"'rt Failure I I Monitor· From : 
Hyperlip1daerniH I To : 
l 
Chrom~ ObstruclivP. Pulmona'Y Drsea~t' j 
' 





Report on worst case scenario in previous 24 hours Report on worst case scenario In previous 24 hours 
Date Date 
RESPIRATORY SYSTEM NEUROLOGICAL SYSTEM 
Respiratory arrest w1thin 24 hours " Glasgow coma scale .::_ 8 •' 
Mechanically ventilated with FiO' :=:. .6% "' I Glasg<Jw coma scale 9- 12 • ----4------------------------· ·- 1--· -·--Mechanically ventilated •· Glasgow coma scale 13-14 i 
Non1nvas1ve Pos1t1ve Pressure Ventilahon • • Raised intra cranial pressure • 
I 
I 
Extubated <24 hours ·- Status Ep1lept1cus " 
Intubated but not ventilated ·- Occurrence of seizures in last 24 hours 
Oxygen 0 2 > 40% • Ventricular drain •• 
Satur;:~tion <90% on 0' ~40%' Polyuria 
Respiratory acidosis • I 
' 
Brain I Spinal surgery 
Respiratory alkalosis • 
Respiratory rate >30 per minute • RENAL SYSTEM 
Bronchospasm I Stridor ' Serum creatinine 1.5 x baseline OR 
<2 hourly nebulisations Unne output <0.5ml/kg x 6 hr • 
<2 hourly suctioning Serum creatinine 2 x baseline OR 
Tract1eostomy Urine output <O.Sml/kglhr x 12 hr • - ------ --·-···-~ 
CARDIO VASCULAR SYSTEM Serum creatine 3 x baseline OR 
Cardiac arrest Within 24 hours .. Urine output <0.3mllkg/hr x 24 hrs OR 
Sternotomy <24 hours ... Anuna x 12 hrs •• 
Acute MI-l Trop 1/T " Acute renal dialysis " 
Angina • Chronic renal failure • 
lscha(lmic ECG changes • Metabolic acidosis • --t - -PTCA" I Stcnt" <12 hours Metabolic alkalosis • 
Ablation · I Rotablator • <24 hours I 
Acute Dysrllytllm!a • I OTHER 
Elect1ve Cardioversion < 12 hours - MaJOr blood lransfuston " 
Temporary Pacemal-.er-dependent -· Autotransfusion ' 
Perm. Pacemaker- post insertion 12-24 hrs' Epidural· 
Vasopressor I Positive lnotropc dependent •• Post-operative monitoring • 24 - 48 hours 
Vascular Stent < 12110tJrs'" Cont. Invasive/non-invasive monitoring 
-------·-·--· · ·---·------ <• ---- ·--
Hypovolaem1a • ::: 4 hours every 15-30 minutes·· 
Tachycardia Pyrexia >38.3•c 
Bradycardia Subnormal temperature <35.s•c 
Hypotension 
Hypertension 
lncreas~1d capillary leak w1th edern;;. I --




Reoort on worst case scenario in previous 24 i1ours Report on worst case scenario in previous 24 hours 
Date I Date 
MEDICATION lVI MONITORING / INVASIVE LINES 
.. ~;;::~~~;;~~;·~':~;i~~~~~P..??.~ ::.. .. ......................... - ............................. - ..................... ----- ...... ---!------- ~ ~~~~~-------·----·- .,_.__ -------1-------~--+---- '·-----· .  _ ...... .. 
~~- ~·--~-r----t-+~==t---+== 
s··· .. 1 I f.lr • l 
-,j~~~~-;:-.~~-\1~~~-~-----------------r--------- ------r---~~~~-o:-;~·~;;r;;;·~-;~;z;;~9-:---- ------~----1---t-------·- - - --
Muscle relaxants:____ j I Noninvasive cardiac output monitor I 
~~~~-an_n_e~~o __ c_k_er_s_'_' ----.. -----------------+--+---+--+----!-----l----+--+-c_v_P_Iin_e _________ ·---·---- __ ---~~--r---jT __ ----.  _____ .. -----·--
Diuretir.;s Acute dialysis catheter 
TPN l I I 
Transvenous pacing •• 
I . L Opioids ~ 
~·-ec-.e-d.e_x_{_· · ·---------.... ·---------.. - ----------- ....... ______ ---.. --·-r·-----.................... _______ .. _ -·------T-·-- EMERGENCY PROCEDURES WITHIN 24 HOURS 
Transcutaneous pacing •• f-----------------.._--J.. __ ..___ _ _._ __ ,__ _ _._ _ __._--t ... -........... ____ ,__ .....;_ ____ _ --+---1----j__ _________ j .............. . 
LABORATORY IMBALANCES Intubation •• [ I 
~H-y_p_o_S_e-,r-u-:T_l _N_a __ -~--~3-0--n-ln-lo-,l-fl----------------~----~----~--~----~-----r----,-----t-E-m_e_r_g_e_r·-.c-y_T_r_a-cr-le_o_s_t_o_m_y_•_• ________ -r--~---t~---·- I 
~----------4--~--+-~--+--~--~----f--~~~------~----
Hyper swum Na ~ 150rrHnol/1' J.. Pericardia! tap 1st 24 hours*' -------r-------... t----L ___ J---·-- _______________  
Hypo serur;K-+ -. ---·-----·--------------+-----+---+·--+----t---f--- ---r--· .. Emerge~~dioversion .... 
1 
1 
Hyper serum K - --------... ----------1-----+---t----t---t---~i---t-----t--D-e-fitlrillation ' · I . ..r---------
.!.1Y!.~.-~:r_:~.:_~~J-'~_:~:_~--·--· · ---.................. _ .. .............. _ ·------r------.. -1---·- --·- ·------+- ·--·---,!-------··+-'-n_te._rco_s_t,_al_d_r_a_in_s _____ . ____ _ ____________  ........................................ .j.. ..... - .. --f-·---.... ---+-.. --.. - --+--- -- -- -------· 
Hyper serum glucose 
Increased SHrum osmolarity ' ! I I 
...... ----------- ----------------·----- ------- ·------+----------~-----·- ----.. -r------1- -----------r---'--- +------l.--t--..1...---f---'----i 
Raised Bilirub1n _ -f...-----i ~~----+--+l --+---+l __ + __ __:l~n~tr:..:a:..:v:..:e~n:..:o:..:u:..:s:...M:.:....::e:..:d~ic:..a:..:t:..:io:..n:.:....::w:..:i~th_** ___ +-D:...a:...t:...e_S_t_a_rt __ +-T- i_m_e __ s_t_a_rt--t-D-a_t_e_s_t_o.:...p-1f-T-i_m_e __ S_to-'p~ 
Acute Hb <89r/diiL • 
Raised cardiae rnarhm; ' I 
----------1~---+---t----+---
Abnormal hi9h levels of therapeutic medication " J ----·-------+---+----+---~-+--f---+------------------+-------i~----- ---f---------1-------i 
To xi(; levels ot medication ..... i 
--------------------+--.... -------- _____ .__ c---------!-·-·...:... ___ _ 
·~~;-~~~~;,~i~~-~~-~~~. _____ ................... -..... --- --1----r----t-----r-----r---·------------··-------------------- __ ... ,.._ .. ____ ____ ........................... ......... -----.......... _ ...............................  -..............  
~---------------
Positive DIC Screen " I ...... -------·-............ - ...................................... _ ... ______ _____ _ ......... __ .... ............. _L ____ -!---!···-----1----·--+-·-.. f-·--------·-------------... ----·---- - _____ ..... _ ....... ---.. ---- ---· ........ _____ .............. _ 
-~-~-!.:.~0...:.. ..... ............. ................ ,_______________ ·· ·· -- .... ---·-·· ................ ! ............ ....... ---l--·-··-·•1· ........ --+ ----·---··-f------------·----------·--·-·"'·-------- ----·-----
Haiscd serum amylase ' L i 

















INTRAVENOUS MEDICATION KEY ORGAN FAILURE 
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Case mix refers to the characteristics of patients served by a health service provider, where  
some patients are at greater risk of having less successful treatment outcomes than other  
patients. Health service providers have no control over these characteristic and therefore the  
need exist to keep them fixed in comparative analysis. The ability to measure heterogeneous  
case mix of hospitals has been recognized for some time as a critical ingredient for  
improving the management of hospitals and health systems through planning and quality  
assurance, as well as achieving equity in hospital reimbursement. Without the capability to  
measure case-mix differences, the comparative analysis of hospital outcomes and attempts  
to establish the reasonableness of those outcomes often reflect in oversimplification of the  
issues involved and may result in spurious and misleading findings.  
History  
The case mix concept has been introduced in the USA more than twenty-five years ago in  
order to measure hospital productivity and to promote quality of care. The DRGs (Diagnosis  
Related Groupings), developed by a team of researchers led by Robert Fetter and John  
Thompson at Yale University, were selected by HCFA (Health Care Financing System) in  
1983 as the case mix classification system for the MEDICARE prospective payment system  
(PPS).  
The DRG was the first “health management tool” to group patients in clinically meaningful 
categories  with  homogeneous  resources  consumption.  All  diagnostic  categories  and 
procedures based on medical record summaries could be coupled with financial data about 
resource uses, for individual patients, in order to differentiate high and low cost care. Even if 
shortcomings were underlined since their beginning, DRGs are still used in the USA as the 
main tool for case based, clinical encounter focused, payment.  
Many other countries have adopted the case mix concept after long periods of testing and  
accepting, but with large variations in data collection, information standards, grouping tools,  
financing methods and quality of care developments all over the world. Each country has  
developed a local clinical and political culture about case mix tools. Case mix development  
in South Africa is being driven by the private health sector for their own use, namely to  
improve the standard of clinical data used in interactions in the industry. These include a  
range of financial uses from information system creation, budget setting and contracting  
around alternative reimbursement models. The CMS (Council of Medical Schemes) are  
developing  an  awareness  of  its  value  within  the  sector.  However,  this  is  a  recent  
development and previous attempts by 3M and by a handful of university and parastatal  
based academics did not achieve sufficient impetus.  
Analytical Approach  
Medi-Clinic is under increasing financial pressure to improve outcomes with fewer resources  
available. Therefore the need exists to evaluate units in our business in a justifiable manner  
(controlling differences in characteristics of patients treated in each unit) in order to focus  
resources in the right areas. We therefore evaluated the DRG system to address case-mix  
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differences in our units. The system is designed to produce groups of patients homogeneous  
with respect to some measure of resource use (LOS or cost) and is undoubtedly one of the  
best-known methods of patient classification, but limitedly takes into account severity of  
illness by including indicator variables for the presence and absence of surgery and in some  
versions comorbidity. Furthermore DRG is based on the principal that diagnosis drives cost  
in contradiction with our faith that costs are driven mainly by procedure or treatment.  
We believe that a lot of detail about the type and severity of a patient which is both  
meaningful  and  readily  available  comes  from  the  codes  on  the  discharge  summary.  
However, the number of possible codes is too large to handle without collapsing them into  
groupings. We therefore have adapted the CCRG (Clinical and Cost Related Groupings)  
which is a unique in-house system of mutually exclusive groupings of CPT-4 (Current  
Procedural Terminology), ICD-10 (International Statistical Classification of Diseases) and  
SADA (South African Dental Association) codes into a hierarchical structure of subgroups,  
groups and categories. We also implemented a computer algorithm deciding which codes  
explain the outcome the best.  
We developed the HRM (Hospital Risk Model) which entails a generic method that permits  
the actual outcome (costs, length of stay, mortality- and other quality outcomes) to be  
compared to statistically modelled “expectations”, given the mix of patients at a level.  The  
method will statistically account for the number, mix and severity of cases because outcome  
variables are dependent on these factors. The model further provides breakdown analysis to  
quantify the magnitude of impact and interactions of these variables to assist in making more  
informed decisions.  
The basic strategy employs the specification of a mathematical equation describing the  
outcome of interest as a function of a set of explanatory variables by means of OLS  
(ordinary least squares), GLM (generalized linear models), logistic or multinomial stepwise  
regression techniques. The explanatory variables describe characteristics of a case that are  
expected to affect the outcome (such as the clinical condition for which was rendered, the  
presence of other conditions that could complicate the stay and the patient‟s profile). These  
equations are estimated, that is, numerical values are computed for the parameters of the  
function that describes the impact of each “explanatory variable” on the outcome variable.  
Case mix can then be accounted for by computing the value of this function, using these  
estimated parameters, for the data values representing the specific characteristics. The  
result of this process is an expected value that is a mathematical function of a hospital‟s  
case mix, severity and demographic profile of the patients.  For example, a hospital that  
treats more severely ill, elderly people will be expected to have higher costs than a hospital  
that treats a generally healthy and young population for a similar set of procedures.  
Although calculations can be complex, interpreting the output is relative easy to do. The  
model makes use of the index methodology to describe the magnitude and importance of  
differences. It is convenient to group explanatory (characteristic) variables to belong to one  
of two mutually exclusive groups: those which are demographic or contribute to the disease  
status or degree of illness of the patient (patient-level factors) and those which represent the  
hospital environment or determined how a patient is cared for from hospital admission to  
discharge (hospital-level factors).  The underlying strategy is to divide the actual observed  
outcome by the predicted outcome on the basis of patient-level factors. This result, defined  
as the index, provides information about the percentage deviation from the expected. If the  
 






index is greater than 1 the patient has had a higher outcome than expected; if negative, the  
outcome was lower than expected. Random variation might explain part of any such  
discrepancy in an individual patient. However, if the overall index is significantly greater than  
1, this presumably reflects hospital-level factors which tend to lead to a negative outcome.  
Similarly an overall index significantly less than 1 will reflect hospital-level factors that tend to  
lead to positive outcomes. In order to determine significance of cut-off levels we apply  
parametric or non-parametric statistical control limits, depending on the type of situation, to  
determine acceptance and rejection regions. Figure 1 below illustrates the application of the  
index methodology for hospitals.  
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Model Validation  
The question will arise to exactly what extent and how accurate the model describes risk in  
reality. We realise that model validation are essential parts of the model development  
process if the model are to be accepted for decision making, so not only do we strive to  
design our coding and grouping systems to accurately reflect reality, we also make use of  
statistical and model designing techniques to validate the model. Often the validation of a  
2  
model seems to consist of nothing more than quoting the coefficient of correlation  R  
statistic (statistical measure that represents how well the model approximates real data  
2  
points).  Unfortunately, a high  R  values does not guarantee that the model will describe 
reality well. In order to address this issue we have designed the model building process to 
remove random effects, hence improve the model fit and consistency. The diagram below 






















































Significant Variables  
 
The process basically entails the selection of two random samples from the original dataset. All 
risk variables defined are fitted through random sample 1 to come up with a list of 
significant variables. These variables are then fitted on the second random sample in order to 
remove random significant variables identified in the first phase. These variables are then fitted 
on the full dataset to calculate the final model parameters. The model is then fitted on an 
independent sample and actual values compared to statistical modelled expectations. If the 
modelled values do not closely describes the actual outcomes, model parameters are 
reevaluated iteratively until a satisfactory level of accuracy is reached.  
Trends & Analysis  
Another application of the capability to measure case-mix differences is the ability to do 
comparative analysis over time. We would like to share some of the interesting trends we have 
identified with the reader. It is important to note that in order to do this type of analysis one 
needs to look at all patient-level factors to get the full picture of patient risk in order making 
the right interpretations. Also it is important to note that the trends are for Medi-Clinic in general 
and will not necessary be the same for different components of the business. Medical 
insurance legislation changes for example can cause trend changes for the insured population 
that will not necessarily impact the private population.  
Figure 3 indicates a decline in patient-level risk over time. The four lines on the figure 
represent four different models based on four different years. The spread between these lines 
will be representative of inflation differences. It is worthy to note that the four models are 
consistently showing the same seasonal trends, which is an another indicating of 
accurate and reliable model results. Why are we experiencing this trend, while at the same 
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7 8 9 
10  11 
12 
 1 2 3 4 5 6 7 8 9 10 11 12  
2004 39.4 39.5 39.1 38.8 38.5 38.3 38.2 38.3 38.2 38.3 38.5 38.4 
2005 39.6 39.6 39.2 39.0 38.9 38.6 38.5 38.6 38.6 38.7 38.8 38.8 
2006 40.2 39.9 39.5 39.1 38.9 38.7 38.6 38.8 38.7 38.9 39.0 39.0 
2007 40.3 40.2 39.7 39.3 39.2 39.0 39.0 39.0 39.0 39.1 39.2 39.2 
To explain this we have done a breakdown to understand which patient-level factors are  
causing the declining trend. We have decided to exclude outpatient cases, since emergency,  
wound care clinics and other outpatient units have grown considerable over time, hence  
impacting on the overall case-mix outcome. Also from an administrative point of view, more  
emergency-admission accounts are now split-billed that were previously billed as one  
account. This digress the number of cases and cause a diluted decrease of patient risk over  
time. Therefore we concentrated only on cases with theatre time or accommodation for the  
purpose of the analysis. Figure 4 illustrates the change in some of the different components  
of patient level risk namely age, gender, surgical- and medical-mix in general.  
 
 






Figure 4 - Overall Risk Breakdown Comparison 
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The first thing to note from Figure 4 is that the overall risk (green line) is still declining with  
the outpatient cases removed from the analysis. It is apparent from the graph that although  
the ageing of the population had a positive impact on the risk change, the overall risk change  
was dominated by decreasing surgical- and medical-mix changes indicated by the negative  
slopes of the respective trend lines. The medical risk 
change tends to dominate the impact on the overall  
risk over time. This is most probable caused by the  
increase in the portion of medical cases relative to  
surgical ones as illustrated in Figure 5. Interpreting  
this trend in combination with the decrease in medical  
risk, it can be an indication that the growth in medical  
cases is supplemented by an increase in low risk  
cases. 
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Figure 4 also shows a decline in the surgical risk of patients. We needed to have a better 
understanding of this, since it is not only contradictive to the ageing and increasing average 
theatre time of the population, but also in important from an operational point of view. We 
investigated the relation between age, gender and surgical risk. Figure 6 is an illustration of the 
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The solid and dotted lines represents surgical risk within each age category for 2004 and  
2007 for females and males respectively and the spread will reflect the differences in  
surgical risk. The green bars indicate the change in specific age categories between the  
respective years. Positive values will be an indication of positive growth within the specific  
age category between years; similarly a negative value will indicate drops. Having a closer  
look at age categories B11-B15, clearly indicating growth in the older age categories, we see  
a drop in surgical-mix for the same categories as indicated by the spread difference. We can  
thus conclude that the change in surgical-mix outweighed the age risk change resulting in an  
overall declining surgical risk. In an attempt to understand the change in surgical mix we  
have done a further in depth analysis looking at the surgical procedures that are strongly  
correlated with surgical risk. The results are set out in the table below.  
Procedure Risk Category Annual Change 
 
Mitral valvuloplasty replacements High -6.490% 
Aorta valvuloplasty replacements High -0.930% 
Gastrectomy High -5.320% 
CABG High -3.280% 
Ophthalmological surgery Low 10.080% 
Plastic & Reconstructive surgery Low 5.370% 
Obstetrics and gynaecology Low 7.420% 
Minor Uro-Genital surgeries Low 6.970% 
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We conclude that the drop in surgical mix was caused by some high risk procedures, but to a 
greater extend by an increase in a high number of low risk procedures. This fact together with 
the decrease in medical mix is the main drivers for a declining overall patient risk. 
Understanding the components of patient level risk is complex because of the intricate 
relation that exists between factors and therefore it is important to look at all risk factors to 
avoid oversimplification of the issues involved.  
Summary  
This analysis demonstrates the feasibility to have a case-mix adjustment system, using 
existing administrative data. The multivariate models used also shows that certain 
patientlevel characteristics could explain variations in risk. However, for a variety of 
technical reasons, the detailed results from these models should be interpreted with great 
caution since correlation between variables could lead to misinterpretation.  
Mortality 
Mortality as a quality outcome?  
Healthcare providers have always been concerned about patient outcomes and evaluating  
outcomes as a means of determining the effectiveness of care. Much of the philosophical  
basis for outcomes measurement is derived from the early work of Florence Nightingale.  
Nightingale used mortality statistics to portray the low quality of care provided to British  
soldiers during the Crimean War. It has been said that Nightingale was the first person to  
use diagrams for presenting statistical data. Although this is most probable not true, she may  
have been the first to use them for persuading people for the need for change.  Her methods  
indeed succeeded by reducing mortality from 60% at her arrival to 2% six months later.  
That fact that patients die in hospitals every day is both an accepted fact of hospital care  
delivery and a reflection of avoidable hospital inefficiencies. These inefficiencies are subject  
to control and include poor infection control, inadequate or inappropriate use of medication  
falls  as  a  result  of  poor  supervision  or  understaffing,  mistakes  during  surgery,  and  
inappropriate level of care. Some, perhaps many, of these deaths might be prevented if a ll  
the factors that contribute to them are better understood. A study, for example, looking at the  
association  between  patient-to-nurse  ratio  and  patient  mortality  concluded  that,  after  
adjusting for patient and hospital characteristics (size, teaching status, and technology),  
each  additional  patient  per  nurse  was  associated  with  a 7%  (odds  ratio,  1.07; 95% 
confidence  interval, 1.03-1.12)  increase  in  the  likelihood  of  dying  within 30  days  of 
admission. Surely hospitals do not have control over worsening nursing shortages and 
legislation changes, but can use this information to address problem areas and optimally plan 
resources. The adjusted ratios should be seen as a kind of red flag for performance 
improvement and not a verdict.  
As in most improvement efforts the process should start with measuring outcomes. It has  
been stressed in the case-mix article that these types of comparisons have little meaning  
unless adjustments are made for patient risk differences. One could thus conclude that  
hospital mortality rate, appropriately adjusted for patient risk variables, is an essentiality in  
measuring quality.  
 
 




Methodology Used  
We have developed a statistical methodology to adjust hospital mortality rates for patient 
level risk factors in order to make justifiable comparisons between hospitals. We also 
expanded this methodology to measure trends over time.  
We treated deaths as a binary response variable and used a logistic regression model to  
measure the relation with patient risk variables in order to adjust for case-mix differences.  
The outcome is an expected value per admission reflecting the probability that the admission  
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The coefficient ˆ in the logistic model estimates the change in the log-odds if x is 
i i 
increased by 1 unit, holding all other x's  in the model fixed. Therefore the model can also  
produce an estimated increase in risk for each of the various risk variables. For example a  
patient odds of dying in hospital, treated for an Infectious or Parasitic disease, will increase  
with a factor of 1.17. More specifically, a patient treated for Tuberculosis, will have a 2.12  
increase in the odds factor of dying in hospital.  The difference in magnitude between the  
coefficients of these risk variables are a reflection of the dependence with the outcome  
variable.  
Trends & Analysis  
The chart below is an illustration of mortality outcome of Medi-Clinic hospitals using  
statistical control charts. The horizontal axis represents volume and the vertical axis mortality  
rate. The curve lines are the control limits defined as 90%, 95%, and 99% confidence  
intervals with the purpose to identify units whose performance diverse significantly from the  
norm. The green dots represent crude mortality and the red dots risk adjusted mortality. The  
solid green and red line is the chronological accumulative mortality outcome of a single  
Medi-Clinic hospital, known to treat high risk cardiac cases, for crude and risk adjusted  
mortality respectively. The spread increase rapidly because of the high risk nature of these  
patients and the crude mortality are quickly out of control. The risk adjusted mortality stays  
within control, indicating that although the crude mortality is significantly higher then the  
norm; it is mainly contributable to patient level risk and not a reflection of inefficient hospital  
processes.  
The idea is to measure this on continues basis and flag hospitals as soon as the outcome 
(mortality rate) is out of control. Doing this will ensure that high mortality rates, contributable to 
inefficient hospital processes, are proactively identified and managed, rather than a 
retrospective review at the end of the financial period. Understanding the issues involved will 
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Like mentioned earlier it is also possible to do trend comparisons over time. The graph 
below illustrates crude and expected morality for Medi-Clinic for 2004 to 2007. It is important to 
note that although the crude mortality rate is increasing, the expected rate is also 
increasing, indicating an increase in the population risk for mortality.  
 
 




Modelled Risk  
































The reason for this increase can be explained by a change in various risk factors, but the main 
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(1) Ageing of the population. Figure 1 shows that there is an exponential relation between 
mortality risk and age, apart from neonatal cases. Figure 2 shows that our population is 
ageing, hence one could conclude that our mortality risk is increasing due to an increase in 
age of the population.        














Figure 2 - Medi-Clinic Inpatient Population Ageing Avg Age 



























(2) Increase in the proportion of medical cases relative to surgical ones as illustrated in 
Figure 4. Figure 3 shows that mortality risk for medical cases are higher then for surgical 
ones, hence one could conclude that this is another reason for the increase. 
   
































































2006 2007  
(3) Increase in HIV related cases. Legislation and patient confidentially does not allow  
information around HIV cases to be captured, hence we needed to use clinical criteria to  
identify certain procedures that can be used as a proxy for HIV cases. Figure 5 shows that  
HIV-related cases have a higher mortality risk then the rest. Figure 6 shows a growth in the  
portion of HIV-related cases relative to the rest, hence another reason for the yearly increase  
in mortality risk. 
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Section B  
 
Hospital Standardised Mortality Ratio and related fields is a very wide subject encompassing a 
large body of knowledge.  The limitations and scope of the dissertation doesn’t allow for a 
literature search on such a wide topic.  The high burden of disease of HIV and related illness 
in South Africa has a substantial influence on the clinical outcomes and as such the literature 
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List of Abbreviations  
 
ART Antiretroviral Therapy 
 
HCFA Health Care Finance Administration 
 
HIV Human Immunodeficiency Virus 
 
HSMI Hospital Standardised Mortality Index 
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NHS National Health Service 
 
SMR Standardised Mortality Ratio 
 
UK United Kingdom 
 
USA United States of America 
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Literature review  
 
Introduction  
The management of quality and care delivered to patients is dependent on the ability to  
accurately measure clinical outcomes. (1)(2) Mortality is used as one of a range of clinical  
quality measures used both as performance, as well as benchmark measure in comparing  
hospitals. (3)The main purpose of the research project is to compare the expected mortality  
rates as calculated by an administrative predictive scoring model to that of a physiological  
predictive model. This literature review focuses on the attributes of the Hospital  
Standardised Mortality Ratio (HSMR) as well as the influence of the Human  
Immunodeficiency Virus (HIV) on the predictive modelling. The availability of ART has  
changed the management of HIV and resulted in a reduction of mortality rates. Most  
mortality prediction models, including the one used by the researcher’s healthcare  
organisation to calculate the expected mortality rates, was developed before the  
widespread implementation of antiretroviral treatment (ART) and may not accurately reflect  
the associated risk. However, by 2013 South Africa had 6 million people infected with HIV  
and 2.6 million people on ART.(4)  
Firstly, the general development and applicability of the expected mortality models is  
discussed before presenting a systematised review of the literature on HIV in relation to 
predictive models to determine the influence of ART on all-cause mortality in HIV infected 
individuals in South Africa in the light of the current coding systems.  
 
Background  
Healthcare is a very complex process with a large number of non-linear inter-related  
variables and a low signal-to-noise ratio.(5) There are many “signals” in the healthcare  
environment mostly related to clinical events or trigger thresholds that alerts the healthcare  
staff to a change in patient condition.(6) The alarms, designed to improve patient safety, can  
become a hazard if they are ignored.  Healthcare staff often ignores these alarms if there  
are a high number of false alarms, as a result of a low positive predictive value. Non- 
standardised alarms contribute to this phenomenon. (7) Similarly, the number of potential  
adverse events, preventable or actual deaths is low in relation to the number of outcomes  
i.e. “low signal-to-noise”. The outcome is often influenced by a number of factors not  
related to the quality of care. (8) Variables included in measurements are routinely collected  
from inexpensive, administrative data mainly used for rendering an account. The findings  
during chart reviews often do not correlate well with the findings from administrative  
scoring models. (9) This limits the use of administrative data to quantify the quality of  
clinical outcomes.(10) Findings from predictive scoring models using administrative data as  
proxy may therefore not be externally valid beyond the hospital from which the model was  
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developed. As a result, secondary use of such data in other hospitals may result in unfair  
labelling due to biased conclusions or inaccurate data.(10) The use of diagnosis-specific  
outcome indicators derived from administrative data still needs refinement and can’t be  
promoted in the current format. (10) Peter Pronovost, founder of the United States (US)  
Quality and Safety Research Group, and Richard Lilford, director of the United Kingdom’s  
(UK) NIHR Collaboration for Leadership in Applied Health Research & Care for West  
Midlands, state that the quality of administrative data contributes significantly to the 
accuracy and reliability of outcome measures. (3) Proxy measures constructed with  
routinely collected administrative data is generally used to gauge the quality of care 
provided and benchmark hospitals. (11)Pronovost et al. made five recommendations for 
improving the quality of administrative data used as outcome measures: “ensure validity 
and transparency, develop standard surveillance, evaluate performance over time, build 
tools to prioritise measures and create an independent agency”. (3)  
Healthcare quality measurement can be divided into indicators for: volume, structure,  
process and outcome.(8) Measures that relate to volume, measure the number of  
procedures performed. As a rule of thumb, higher numbers, especially with regards to  
specialised procedures, are associated with improved outcomes. However, this association  
has not been proven in non-procedural care.(12)  Structural measures relate to the  
accreditation and certification of practitioners and institutions. Process measures describe  
whether evidence based care processes is followed.(12) Outcome measures are believed to  
reflect the interplay of volume, structure and process; hence they are regarded as a  
reference standard. (8)  
 
Standardised Mortality Ratio (Administrative data)  
Death is an unambiguous, binary variable and reflects an outcome critically important to  
patients.  A standardised mortality ratio (SMR) is one means to quantify the quality of care  
delivered in hospitals. The US Health Care Financing Administration (HCFA) was the first to  
publish such data in 1986. (13)  The use of SMR as a measure of outcome was later  
discontinued, as the validity of the indicator was questioned. (14) Jarman et al. were  
commissioned to redevelop standardised mortality measurements for the UK National  
Health Service (NHS) in 1999.(15) The original model, amended by The Doctor Foster  
Intelligence Group, is used to calculate SMR’s for English hospitals.  Wide annual publication  
of the results started in 2001.(16) USA, Canada and the Netherlands currently publically  
reports on the hospital standardised mortality ratio (HSMR) and views it as an important  
clinical outcome measure.(17)  
Crude hospital mortality ratios can’t be compared directly as there are a number of factors,  
not related to quality of care, that may influence the rate. (18)Hospitals that treat patients  
who are younger or of lower acuity may have a lower HSMR and seem to perform more  
favourably, as compared to hospitals treating older and/or more complex cases that  
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subsequently may have higher indices and may therefore be perceived to perform poorly.  
(18)  
The HSMR is used to rate, compare and track hospital performance over time. Pouw, et al. 
stated that the HSMR of different hospitals can only be compared to one another if the  
underlying distribution of case-mix variables is exactly the same or if the underlying hospital 
factors do not interact with the case-mix variables. (17)The case-mix of a hospital may vary 
over time and the changes in HSMR may be due to changes in case-mix and may not reflect 
the quality of care provided. (17)  
As alluded to above, the prevailing case-mix within a hospital can have a profound impact  
on a number of measures, including the HSMR. Direct or indirect statistical standardisation  
methods are used to adjust for these differences.(17) These methods take a number of  
patient related factors into account such as age, comorbidities, deprivation score, reason for  
admission, etc. when adjusting. Direct measures standardise the case-mix to a reference  
population and across institutions. An expected mortality rate for a specific subgroup of  
patients is calculated e.g. acute pancreatitis in women aged 40 - 60 years old.(17) Indirect  
measures standardise the mortality rate to a reference mortality rate. Indirect  
standardisation methods are sensitive to changes in case-mix, while direct mortality  
standardisation is not influenced by differences in case-mix. The use of direct  
standardisation in practice is limited by sufficient volume of cases in subcategories.(17)  
Indirect standardisation calculates the expected number of deaths, using a logistic  
regression statistical model and a number of predetermined variables, and compares this to  
the actual number of deaths. (17) The mortality index is the actual number of deaths divided  
by the expected number of deaths and the index should ideally be ˂1. (17)  
 
A number of factors not related to quality of care may influence the SMR  
Case-mix adjustment (with models derived from indirect standardisation)  
Case-mix adjustment is not a perfect science as it can only take into account previously  
identified and accurately measured factors. However, it is still believed to be fairer than  
comparing crude mortality rates.(19) Mohammed, et al. emphasised that case-mix  
adjustment may in itself bias HSMR. (13) Case-mix adjustment is influenced by the number  
and type of variables, the distribution of the variables in the population and the interaction  
between the case-mix variables and the hospital. (13) In order to achieve accurate case-mix  
adjustment, one needs the relationship of the variable and associated mortality risk to be  
constant amongst all populations (constant risk relationship), as a paradoxical increase may  
occur when the variable is unevenly distributed amongst the population (case-mix fallacy).  
(13) The number and selection of variables that are taken into account when adjusting for  
case-mix will also have a profound effect on the case-mix.(17). The use of SMR as a  
screening test results in a test with a high sensitivity and low specificity. (18) It is desirable  
to have a high sensitivity as one would not want to miss underperforming hospitals.  
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However, false positive results may lead to the wasting of resources that could have been 
better utilised in addressing clinical risk. Hospitals may also be falsely labelled as poor 
performers and staff may manipulate data to improve the rankings, known as “gaming”. 
False negative results may allow critical care failures to be undetected.(18)  
A focus on reducing mortality rates may also influence treatment decisions and lead to  
aggressive treatment of patients with a poor prognosis and lead to related inflated  
healthcare costs.(19) Girling, et al. state that SMR isn’t a suitable means to diagnose poor  
patient care if the percentage of preventable deaths is less than 15% of all deaths. (14) They  
also state that “most studies measure a proportion of deaths for which a potentially  
preventable factor was present, rather than an estimate of the proportion of deaths that  
were in fact preventable”. (14) The preventability of deaths varies across hospitals and the  
aggregation of data from a number of units to calculate hospital-wide SMR may dilute the  
results of specific poorly performing units. (14) The attribution of unexplained variation to  
poor quality of care may be erroneous and an example of the case-mix adjustment fallacy.  
(20)  
Diagnostic coding  
Diagnostic coding is used to translate the patient’s baseline clinical condition on admission,  
course of illness, management of illness and procedures performed to a standardised  
codified format that describes the episode of care.  Diagnostic coding is also used to render  
an account.(21) Diagnostic coding is bound by strict definitions and rules. In spite of this,  
Hawkes, et al. state that research done by a healthcare analytics organisation (April 2005 to  
June 2009) illustrates that the number of codes per account has increased steadily and  
varies greatly amongst hospitals. (21) The inconsistent application of coding rules and  
definitions leads to poor coding practices. Inaccurate or incomplete coding of care episodes  
may lead to differential measurement errors that may over- or underestimate the expected  
number of deaths. (13) The coding of secondary diagnosis, comorbidities and the  
sequencing of codes on the account may all influence the expected mortality rate and thus  
the HSMR. (22)  
Measures to improve the quality of coding, and especially the number of codes per account 
(coding depth), may lead to an improvement in the SMR that only reflects improved coding 
and not an improvement in the quality of care. (21)  Diagnostic codes cannot distinguish 
between conditions that have been resolved and conditions that have residual effects and 
disability.  This is in keeping with the inability of diagnostic coding to capture the functional 
status of the patient. (18) The severity of illness is not accurately reflected by the coding of 
co-morbidities, and variation in the functional status of patients may contribute to patients 
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Bottle et al. found that different coding practices generally had limited impact on the HSMR  
amongst institutions maintaining good coding standards; however palliative care coding had  
a notable influence and may introduce bias.(24) The ICD code “Z51.5” is used to indicate  
palliative care and Hawkes et al. stated that the use of the code had increased dramatically  
in England over the time period 2004 to 2009. (21) This was in keeping with palliative care  
exclusions. It was also found that the increased use of Z51.5 has led to a decrease in the  
HSMR, even though the crude death rate was reasonably stable.(21) A similar finding was  
made by Christopher Chong when he investigated changes in palliative care coding practices  
in Canada (2004 - 2010) in the time period after HSMR was made public.(25) The  
publication of the HSMR correlated with an increase in the use of palliative care coding and  
a decrease in the HSMR.(25)  
The manipulation of diagnostic coding to decrease the HSMR and improve performance is a 
more sinister result of the publication of HSMR.  (26) Some of the poorer performing  
hospitals may manipulate the diagnostic codes to game the system and improve their  
ratings. Several studies have commented on this phenomenon.(21)(25)(26)  
Discharge practices  
The discharge practices vary amongst hospitals and this has a variable influence on the  
HSMR. (27) Discharge practices may also introduce bias as patients who are discharged to a 
step-down unit, transferred to other hospitals or sent home before dying will decrease the 
number of actual deaths. The actual mortality rate is thus decreased; the expected remains 
the same, thereby lowering the HSMR.(27) This also holds true for the transfer of complex, 
high acuity cases to other facilities. The inclusion of early post-discharge mortality as a  
measure may help to minimise discharge bias and ensure more accurate comparison.  
However, obtaining accurate post-discharge data is, generally speaking, even more difficult 
than obtaining accurate in-hospital data; and none of the short term mortality measures are 
superior as all are able to be manipulated. (27)  
Size of hospital  
The size of the hospital plays a significant role in the stability of the HSMR over time as well  
as the placement of the hospital in the ranking. Smaller hospitals are expected to be outliers  
and are represented at either extremes of the scale.(28)  It is known that smaller sample  
sizes are more prone to variation and a larger deviation from the mean.(29) Statistical  
modelling is one possible means to mitigate the effect but this only leads to a modest  
improvement.(18) It is also found that smaller hospitals may have a very different case-mix  
to the one used in the development of the statistical model, as they may render specialised  











Jarman initially stated that no significant impact was seen on the HSMR if one considered  
number of readmissions over a one year period. (31) Jarman later amended his view and  
concluded that the inclusion of the number of admissions in a given time period may be  
potentially useful.(31) He did not clearly define an optimal time period to choose.  
(15,31,32)  Van den Bosch, et al. found that patients who were readmitted more frequently  
had a lower predicted mortality rate for subsequent admissions. The reason for this finding  
is unclear but it’s presumed to be partly due to differences in case-mix. (20)  
A number of factors unrelated to patient characteristics or the quality of care delivered may  
influence the number of readmissions.(18) One such example is the institution’s admission  
policy. Institutions have different ways in managing specific conditions like cancer.  Some  
institutions may admit cancer patients for treatment whereas in others they may be treated  
as outpatients.(18) The frequency with which patients are treated for a specific condition  
may also be different, as treatment protocols differ, resulting in different readmission rates.  
(18) When patients are transferred to other facilities for more specialised care and are then  
subsequently readmitted to the referring hospital, it counts as a readmission for the first  
hospital (and a dilution of the numerator); in contrast, the receiving institution that treated  
the more complex case it only counted as one admission.(20) Other, unrelated, influences  
like culture, deprivation status and healthcare funding policy may also influence the  
readmission rate.(15) The patients who are more frequently readmitted may be  
fundamentally different from other patients and may be more resilient. (20) It was also  
found that frequently readmitted patients have more comorbidity, as expected, but are on  
average younger. In line with these findings, van den Bosch, et al. suggested that the  
admission frequency be included as a variable in calculating the HSMR.(20)  
Low signal to noise ratio  
The number of preventable deaths (signal) is a small percentage of all deaths (noise) and in  
a paper by Scott, et al. it is reported that 5% -10% of all hospitalised patients die. Most of  
these deaths are not due to poor quality of care but the normal disease process.(18)  It is  
reported that adverse events may lead to increased cost per healthcare event, admission to  
a higher level-of-care or a longer length-of-stay but are mostly not fatal.(18) The HSMR as a  
screening tool has a low specificity (deaths are mostly not due to care failures) and  
sensitivity (most care failures do not cause death).(18) In a study by Scott, et al. it was 
reported that the HSMR was found to be within the normal range in two thirds of poor 
performing hospitals (190 US hospitals with 25% preventable death).(18) A HSMR that is 
within accepted norms can detract from quality improvement needs and obscure poor 
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Low criterion validity  
The HSMR doesn’t correlate well when compared to other quality indicators and it is  
believed to be a poor predictor of preventable complications and poor clinical quality.(33)  
No difference was noted in the quality of care rendered by hospitals flagged as outliers  
when the adherence to best practice measures and disease related quality indicators for  
high risk conditions like acute myocardial infarction, pneumonia and stroke were measured.  
(18)  
A systematic review (31 studies) found that the relationship between HSMR and quality of  
care is variable.(34) In the systematic review Pitches, et al. state that mortality is predicted  
on “three key variables - patient risk factors (case-mix), play of chance and quality of care”.  
(34) Risk adjustment is believed to compensate for the differences in patient profiles. If the  
play of chance is taken into account, the rest of the difference has to be due to the quality  
of care delivered. This is fallacious reasoning as there may be unknown or un-measureable  
variables that have a major impact on the HSMR.(34) Pitches, et al. state: “there are three  
reasons why outcomes may vary even after case mix adjustment: (i) genuine differences in  
process measures of quality of care not measured in the study, e.g. vigilance of nursing staff  
which is harder to measure and therefore rarely captured in the study; (ii) differences in  
prognosis/risk, not captured in the study; and (iii) differences in definitions or in how 
definitions were applied in different places.”(34)  
Difference in reference populations  
The different mortality prediction models include different variables and diagnostic  
categories with the percentage of variables varying from 28% to 95%.(9) A HSMR model that  
does not include all patients in the calculations but excludes certain diagnostic- or  
procedure categories may lead to a biased result.(18) Institutions and healthcare providers  
do not define diagnosis uniformly.  When in-hospital mortality rates were compared to  
condition-specific quality of care measures, no association was found. (35) The models do  
not include measures to weight the severity of illness and functional status of the  
patients.(35) The model may have been calibrated and validated in a specific reference  
population and is now applied to a population that varies significantly in known and  
unknown ways from the reference population, leading to biased outcomes.(36)  
 
Place of death and end-of-life care  
The majority of patients die in hospital, rather than at home. This is largely due to a number  
of factors: the unpredictability of death, complexity of illness and need for technological  
intervention in palliative care, availability of home and hospice care, the admission and  
discharge policies, healthcare funding models, patient and family preference and culture  
and religious beliefs. (37) These factors are not related to the quality of care or  
preventability of death however has a profound impact on the HSMR.(37) Hospitals not only  
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vary in the number of palliative and end-of-life patients that they admit but also in the 
various other factors that influence decisions and treatment protocols.(38)  
Uncertain stability over time  
The HSMR is believed to be unstable over time and a number of reports highlighted the fact 
that there are marked short term changes in the HSMR. (18) These changes cannot be  
explained by clinical advances, seasonal or annual fluctuations or improved clinical  
outcomes and has raised concerns about the stability of the model over time.(18)  
Variability in measurement  
Shahian, et al. studied the correlation between four different proprietary SMR models when 
applied to the same population. The four different vendor models, when applied to the  
same dataset, gave discordant results. (9) The hospital level measures differed in  
methodology as well as inclusion criteria. The results were very different for the same  
hospital when calculated with different prediction models. A hospital could be branded as 
poor performing with one model and better-than-average with another model.(9) Shahian et 
al. believe the reason for the poor correlation between the models is the exclusion of  
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Table 1: A comparison of some of the features of the proprietary vendor models studied by Shanian et al. and the in-house HSMR  
developed by the healthcare organisation with some of the elements in the table directly copied from a table by Shanian et al(9)  
 
 Characteristics of four vendor methods Healthcare 
organisation 






Diagnostic inclusions 80% of all observed deaths All All 80% of all observed 
deaths 
All 
Diagnostic exclusions      
•    Palliative care   X   
•    Diagnosis and procedures related to 
complications 
  X   
•    Medically treated major or metastatic 
malignancy 
 X    
•    Severe burns or trauma  X    
•    Diagnostic strata with <1,000 discharges X     
•    Diagnostic strata with <50 deaths X     
•    Diagnostic strata with <1% predicted 
mortality 
X     
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Patient exclusions      
•    Neonates   X   
•    Missing or invalid data elements or DRG  X X X  
•    Transfers to another facility X X X   
•    Left against medical advice  X    
•    Length of stay >365 days    X  
Type of model      
Simple logistic regression   X  X 
Diagnosis-specific logistic regression X   X  
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Table 1 (cont.): A comparison of some of the features of the proprietary vendor models studied by Shanian et al. and the in-house HSMR 
developed by the healthcare organisation with some of the elements in the table directly copied from a table by Shanian et al(9)  
 
 Characteristics of four vendor methods Healthcare 
organisation 






Covariates in primary model      
•    Age and sex X X X X X 
•    Race X   X  
•    Socio-demographic factors X   X  
•    Admission source and type X  X X  
•    Charlson comorbidity source    X  
•    Elixhauser comorbidity score X     
•    Multiple interaction terms  X X   
•    Procedures X X X   
•    Distance travelled X     
•    Payer X   X  
•    Month and year of discharge    X  
•    Do not resuscitate    X  
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The elements compared in the table above shows that the in-house develop mortality 
model includes all patients.  
Education and staffing levels  
Aiken, et al. reported on the difference in the education and knowledge levels of nursing  
staff. They found a reduction of 5% in the likelihood of 30-day mortality or failure to rescue  
with a 10% increase in the number of nursing staff holding a bachelor’s degree.(39) In  
another study by Aiken, et al. it was found that every additional patient added to a nurses  
workload lead to a 7% increased risk of death within 30-days of admission, as well as a 7%  
increased risk of experiencing a failure-to-rescue incident.(40) Jarman, et al. had similar  
findings association, with the availability of general practitioners (GP’s) in the population  
surrounding the hospital impacting the mortality rate. He stated that the lower the number  
of GP’s per 10 000 individuals in the population surrounding the institution, the higher the  
mortality rate. (15) Heijink, et al. also found that a low level of GP’s in the areas surrounding  
the hospital has a negative effect on the associated mortality rate. The exact reason for this  
is unclear but it is speculated that GP’s may have a heavy workload, suffer from burnout and  
that this may contribute to poorer decisions on patient care.(41)  
 
Review of literature related to HIV related mortality pre- and post 
ART in South Africa  
Objective  
In the researcher’s healthcare organisation it is generally perceived that the contribution of  
HIV to the burden of disease is highly variable amongst regions and hospitals.  The  
healthcare organisation under review is structured into five regions. The Northern and  
Tshwane Regions within South Africa are believed to have the highest incidence of HIV and  
HIV-related illness. These regions are in the north-eastern geographical regions of South  
Africa and cover four provinces: North West, Gauteng, Limpopo and Mpumalanga. KwaZulu- 
Natal is included in the Central Region. No studies of the data routinely warehoused in the  
healthcare organisation have been conducted to disprove, prove or quantify this perception.  
However, it is known that the prognosis and life-expectancy of HIV-infected individuals in  
South Africa have changed dramatically. This was especially evident in the years after the  
initiation of widespread and decentralised anti-retroviral treatment (ART) programs.(42)  
According to an internal document (2008) detailing the case-mix and standardised mortality  
prediction methodology the author concluded: “Increase in HIV related cases. Legislation  
and patient confidentially does not allow information around HIV cases to be captured; 
hence we needed to use clinical criteria to identify certain procedures that can be used as a 
proxy for HIV cases. Figure 5 shows that HIV-related cases have a higher mortality risk then 
the rest. Figure 6 shows a growth in the portion of HIV-related cases relative to the rest, 
hence another reason for the yearly increase in mortality risk.”(43)  
 



























































































Fig 5 and 6 were copied from the internal memorandum by J van Schalkwyk and as such the 
numbering of the figures is not in line with the numbering in the document. (43)  
The primary objective of the research project is to determine whether administrative and  
physiological predictive scoring models are comparable in relation to the expected mortality  
predictions generated. The influence of HIV and ART treatment programs is substantial and  
may lead to biased outcomes.(42) The diagnostic coding practices in the healthcare  
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diagnostic codes until mid-2010.  The description of the ICD-10 code was printed on the bill 
and an internal policy was to exclude HIV from diagnostic codes for that reason.  
Mid-2010 the format of the accounts changed and the clinical coders allocating the 
ICD-10 codes was instructed to code HIV and HIV related conditions when indicated. .  
Before the coding of HIV the ICD-10 code ‘B33.3’ was used as a proxy. The in-house  
mortality prediction model was developed in 2002, prior to the decentralised widespread  
implementation of public ART programs in South Africa. It was last updated in 2009, and  
B33.3 included in the weighting, however the weighting of all-cause mortality in people  
living with HIV wasn’t taken into consideration. The weighting allocated to HIV in the  
mortality prediction model may overestimate the expected mortality in individuals suffering  
from HIV or HIV-related illnesses. A systematized literature review was thus conducted to  
determine the influence of ART on all-cause mortality in HIV infected individuals in South  
Africa.  
Search strategy  
A search was conducted using the search terms HIV, Standardised Mortality Ratio, all-cause  
mortality, prognosis and Sub-Saharan Africa. The Boolean search string that was used was:  
“HIV AND all-cause mortality AND Sub-Saharan Africa AND standardised mortality rate”.  
Google Scholar, PubMed and EBSCO host was included and 143 publications were identified.  
Five additional articles were sourced from bibliographies. The search included publications  
in English and Afrikaans and placed no limitation on the date of publication. No manual  
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Figure 1: Flow-chart of literature selection  
 
Inclusion criteria  
Publications containing the following information:  
•    Adults and children suffering from HIV or HIV-related illness  
•    Public ART programs as intervention  
•    Studies limited to South Africa to investigate the influence of the decentralised ART  
 programs on changes in the mortality rate  
•    All-cause mortality and/or life expectancy regarded as the primary end-point  
Exclusion criteria  
Publications containing the following criteria were excluded:  
 
•    Diagnosis-specific mortality outcomes  
•    Primary mortality related to other illnesses, for example mortality outcomes due to  
 Multi-drug Resistant Tuberculosis  
•    Studies conducted in or referring to geographical areas in Sub-Saharan Africa with  
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•    Studies referring to other interventions for example initiatives to encourage  
adherence to treatment programs like short message systems or home visits by lay 
healthcare workers  
•    Studies comparing the mortality rate in people suffering from HIV-related illness  
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Table 2: Analysis of selected studies  
 










13,249 14,695 person 
years 
Patients enrolled in 
antiretroviral treatment 
programmes in Cote 
d'Ivoire, Malawi, South 
Africa and Zimbabwe 
(Global Burden of 
Disease Program) 
Median age 34 years and 67% female. 
85% of participants advanced disease. 
Excess mortality rate 17.5 (95% CI 14.5 
-21.1) per 100 person-years in patients 
who started ART with a CD4<25 cells/µl 
and WHO stage III/IV and only 
1.00 (0.55 -1.81) per 100 person-years 
in patients who started with 200 
cells/µl above or with WHO stage I/II 




74,500 2004 - 2006 Adults 25 to 49 years 
living in Umkhanyakude 
district in northern 
KwaZulu-Natal with 
N=7930 deaths (2000 
and 2006) 
Standardized mortality rates decreased 
significantly when compared to 2002- 
2003 from 
22.52 to 17.58 per 1000 person-years 
(25-49 years of age)  and 26.46 to 
18.68 per 1000 person-years in women 
and men respectively 
Bor Prospective 
cohort study 
101,000 2000-2011 Rural KwaZulu-Natal 
Changes in adult life 
Adult life expectancy was 49.2 years in 
2003 before the availability of ART in 
the public sector. Adult life expectancy 
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(2013)    expectancy was 
measured during 2000 - 
2011 
increased to 60.5 years in 2011, a gain 





127,585 487,242 person 
years 
Data from sites routinely 
testing patients for HIV 
in Malawi, South Africa, 
Tanzania and Uganda 
was collected and the 
difference in the 
mortality rate between 
HIV infected individuals 
and HIV negative 
individuals were 
calculated 
Pre ART: HIV-attributable mortality: 45 
to 88 deaths per 1,000 person years 
reducing to 14-46 deaths per 1,000 
person years. The mortality rate (ages 
15 - 54 all sites) decreased by 50% (HR 
=0.43, 95% CI: 0.32-0.58) after the 





73 000  Agincourt Health and 
Socio-Demographic 
Survey site (AHDSS) 
located in Mpumalanga, 
South Africa. 
Data was gathered for a 
health and social study 
Comparing 2007 - 2008 to 2009- 2010 
a 30% decrease in age and gender 
standardised adult HIV-related and TB 
(HIV/TB) mortality was found with no 
change in mortality due to other 
causes. The changes in the mortality 
rate differed markedly amongst the 
communities. The biggest benefit was 
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Discussion of studies included  
In 2009 there were 22 million people infected with HIV in Sub-Saharan Africa. These people  
had a life-expectancy of 10 years if untreated, whereas people living in the more affluent  
industrialised countries treated with ART had a mortality rate comparable to that of chronic  
disease sufferers. The provision of ART is costly and it was only in 2003 that ART became  
more widely available to people living in Sub-Saharan Africa. ART was provided by  
governmental programs and international humanitarian initiatives. Little information is  
available on how the mortality rates in Sub-Saharan Africa differed before and after  
initiation of the ART program.  
In 2009, Brinkhof, et al. studied patients enrolled in antiretroviral programs (Côte d'Ivoire,  
Malawi, South Africa, and Zimbabwe) using information from the World Health Organization  
Global Burden of Disease (GBD) project as well as the International epidemiological  
Databases to Evaluate AIDS (IeDEA) initiative.(44) The cohort included 13,249 patients from  
all sites who were followed up for 14, 695 person-years.  During that time 1,177 people  
died. Women made up the majority of the study participants (67%) and the median age of  
the cohort was 34 years.  In 85% of participants where the severity of illness was known, the  
individuals were severely ill at the start of ART. Individuals starting ART with a CD4 cell count  
of less than 25 cells/µl and/ or World Health Organization (WHO) stage III/IV had an excess  
mortality rate of 17.5 (95% CI 14.5-21.1) per 100 person-years, while individuals starting  
with 200 cells/µl or above with WHO stage I/II had an excess mortality rate of 1.00 (0.55- 
1.81) per 100 person-years.  SMR’s were 47.1 (39.1-56.6) and 3.44 (1.91-6.17) respectively 
over the two years of follow-up. In patients starting antiretroviral therapy with CD4 counts of 
200 cells/µl or above in WHO stage I/II (High CD4 count and early disease) and surviving year 
one of antiretroviral therapy, the excess mortality rate was 0.27 (0.08-0.94) per 100 
person-years and corresponding SMR was 1.14 (0.47-2.77).  
The findings of the study shows that the mortality rate is higher in individuals infected with 
HIV than in uninfected individuals however antiretroviral treatment programs reduce the  
mortality rate.  Individuals starting treatment earlier and with less severe disease have a  
better prognosis and a mortality rate that compares to that of individuals living with chronic 
disease.  One of the limitations of the study is that the authors compared the death rates to 
the national death rates and not with the deaths rates in the specific populations that were 
investigated. This may lead to biased results. However the findings are still significant and 
may be useful for future comparisons.(44)  
Herbst, et al. conducted an open cohort, population-based, study utilising data collected by  
the demographic surveillance programme of the Africa Centre for Health and Population  
studies in the district of Umkhanyakude in northern KwaZulu-Natal, South Africa.(45) The  
cohort included 7930 deaths and participants were followed up for 517 856 person-years  
(January 2000 to December 2006). The prevalence of HIV increased from 1990 onwards and  
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reached 21.5% (15-49years age group) in 2004. The highest being 51% amongst women 25 - 
29 years old and 44% amongst men 30 -34 years old.  
In 2000 mortality was linked to HIV causes in 74% women and 61% men (15-44years);  
however in 2007 it was found that HIV related mortality had decreased steadily although  
the prevalence of HIV remained the same. A steady increase in the mortality rate is seen in all 
age groups from 2000 to 2003 with a decline in mortality rates by 2007. The 25-49 year old 
group had standardized all-cause mortality rates of 24.0 deaths per 1000 person-years in 2000 
increasing to 33.0 deaths per 1000 person-years in 2003 and decreasing to 23.9.deaths per 
1000 person-years in 2006.  
A sharp decrease in HIV related mortality was found when the pre-ART (2002-2003) values  
were compared to the post-ART (2004-2007)  values  amounting to 22.5 to 17.6 per 1000  
person years and 26.5 to 18.7 per 1000 person years in women and men (25-49 years old)  
respectively. It was found that mortality not related to HIV increased in women (4.5 to 7.3  
per 1000 person years) however remained the same for men (men and women 25-49  
years).(45)  
Bor, et al. studied the influence of ART on HIV-related mortality and measured the changes  
in adult life expectancy. Adult life expectancy is defined as: “the mean age to which a 15- 
year-old could expect to live if subjected to the full pattern of age-specific mortality rates  
observed in a population for a given period of time”.(42) Contrary to the methodology  
(United Nations East Asia model life tables) used by the South African government to  
extrapolate age-specific mortality rates, Bor, et al. measured mortality rates directly. The  
demographic surveillance data was obtained from the Health and Population Studies (Africa  
Centre) and was based on the observation of an open cohort (N= 101 286) in rural KwaZulu- 
Natal.  Almost a third of HIV positive individuals (7% of study population) 15 years old or  
older had started ART by 2011.  
In a study by Bor, et al. it was shown that adult life expectancy initially decreased from 52.3 
years in 2000 to 49.2 in 2003. (42)After the initiation of public ART programmes life  
expectancy increased steadily and reached 60.5 in 2011.  This is an improvement of an  
average 11.3 years. It was also found that the proportion of death in young adults declined 
and the median length of life increased by 18.1 years from 42.6 years in 2003 to 60.7 years in 
2011. They found a clear temporal association with the start of the HIV pandemic and the 
associated rise in mortality rates as well as the introduction of decentralised, public ART 
programs and associated decreased mortality rates.(42)  
Mee, et al. analysed data collected by the Agincourt health and socio-demographic survey  
site in Bushbuckridge sub-district, Ehlanzeni municipality in Mpumalanga. The area is  
predominantly rural and houses a large Mozambican population. The project was initiated in  
1992 and by 2010 consisted of 90 000 persons in 16 000 households. The overall prevalence  
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of HIV was found to be 19.4 % (prevalence survey conducted August 2010 and May 2011) 
with the prevalence for females much higher than males, 23.9% versus 10.6%.  
 
The cohort consisted of 105 149 persons, followed up for 320 945 person years and a crude  
mortality rate of 9.0 deaths per 1000 person years were recorded (1 January 2007 to 31  
December 2010).  The majority participants were female (53.2%) with the main causes of  
death HIV related illness 25.1%, pulmonary tuberculosis 19.2% and acute respiratory  
infections 17.0%. The HIV/TB mortality rate decreased by 27% (study time period 2007-2008  
and 2009-2010) and mortality related to other causes decreased by 10% for the  
corresponding time period. Mee, et al. concluded that the establishment of a community  
clinic and the availability of ART contributed significantly to the decline in HIV/TB mortality  
in keeping with findings in a similar study in KwaZulu-Natal where mortality rates decreased  
by more than 50% after ART was initiated.(4)  
 
The mortality rates amongst HIV infected adults were ten times higher than non-infected  
individuals and 90 -95% of deaths was attributable to HIV in the time period before the  
availability of ART. The mortality rates varied amongst the different populations and  
amongst different gender and age groups. (46) A study by Slaymaker et al. was undertaken  
in four regions in Sub-Saharan Africa collecting routine demographic and population HIV  
status information. The data was gathered from four sites: Malawi, South Africa, Tanzania  
and Uganda and collected demographic population-based data as well as HIV status. The  
projects are well established, collect data from epidemiologically different populations and  
has detailed mortality data pre- and post-ART readily available. The study conducted by  
Slaymaker, et al. stratifies the mortality rates in three streams: Five years before ART, five  
years while ART is being rolled-out and five years after established programs are available.  
The cohort consisted of 127 585 individuals age 15 years or older (HIV status known)  
contributing 487 242 person years. HIV-related mortality declined steadily from before ART  
was available to after establishment of ART programs from 45- 88 deaths per 1000 person  
years to 14- 46 deaths per 1 000 person years respectively. A reduction of greater than 50%  
in HIV related mortality (15 -54 years, across all sites) was found after the availability of ART  
when compared to the time period before the availability of ART. The mortality rates still  
remain higher than that of HIV negative people.(46)  
 
Summary  
The in-house hospital standardised mortality model was updated in 2009 without accurate  
data on the prevalence of HIV, or its geographic spread, disease severity and associated  
illnesses like multidrug resistant tuberculosis.  The model may have underestimated the  
severity of illness and associated risk and lead to biased mortality indices, a false high rate.  
The opposite may also be true in that the population served by the private healthcare group  
may contain disproportionately more patients that are comply with first-world criteria and a  
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significantly lower prevalence of HIV and related illnesses.  The improvement in life- 
expectancy of people living with HIV and treated with ART may have contributed to the  
model over estimating the risk of death and in populations with a high percentage of these 
patients may falsely lower the HSMR. The implementation of decentralised ART programs in 
the public sector have reduced the mortality rate of individuals living with HIV in South  
Africa and the reduced mortality rate may influence the risk prediction model.  
Key points arising from the five studies:  
•   The all-cause mortality rate started to increase in the late nineties and reached a  
 high in 2003 (before the onset of ART)  
•    The availability of ART, and especially the accessibility of community clinics providing  
 ART and tuberculosis treatment, was associated with a sustained decline in the HIV  
 related mortality rate - temporal relationship  
•    Mortality not related to HIV declined in some groups, however much less than that  
 of HIV related mortality, and was left unchanged in other studies. The base mortality  
 rate in the community influences the HIV related mortality rate  
•    HIV related mortality rates are variable amongst the different communities. HIV  
 related mortality rates higher rates than the rest of the surrounding communities  
 may be due to micro-epidemics  
•    HIV related mortality rates also vary amongst gender and age groups - young adult  
 females have much higher rates  
•    The availability of ART and the early initiation of ART as well as the adherence to  
 treatment programs have a major influence on the HIV related mortality rates  
•    In more affluent communities where ART is initiated early, the all-cause mortality  
 rate is equal to that of individuals living with chronic disease.  In Sub-Saharan  
 countries the all-cause mortality rate of individuals on ART is still significantly higher  
 than that of HIV negative individuals (4,42,44-46)  
 
Conclusion  
The evidence shows that the HIV related mortality rate is highly variable amongst 
populations. It depends on age and gender groups, and is influenced by the availability of  
ART and the early initiation and adherence to ART. The mortality rate still remains higher  
than that of HIV negative individuals.  The mortality prediction model was developed by the  
healthcare organisation during the pre-ART period (2002).  The model was updated in 2009  
and selected the ICD-10 code “B33.3” as a proxy to try and establish the risk added by HIV  
infection. The inclusion of a proxy measure for HIV is not ideal and may introduce  
measurement errors and biased conclusions.  The nature of the illness as well as the lack of 
good quality clinical information makes it difficult to gauge the accuracy with which the 
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Predicting mortality rates: Comparison of an administrative predictive model 
(Hospital Standardised Mortality Ratio) with a physiological predictive model 
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The healthcare industry experiences ever increasing pressure to provide evidence of the 
value of the services provided to patients and funders.  Quality indicators are seen as a  
means of quantifying value. Yet there is little agreements on which are the optimal  
measures to use.  Death is clearly defined and easily measurable however, most deaths are 
due to the normal disease process. The actual mortalities can’t be directly compared as 
healthcare institutions and patient populations differ.  The biggest challenge is thus to  
accurately and simply predict the risk of death.  
Methods  
A cross sectional study was undertaken in a South African private healthcare group (40  
hospitals with 68 critical care units).  The predicted mortality as calculated with an  
administrative model (Hospital Standardised Mortality Ratio) was compared to a  
physiological model (APACHE ®IV) and considered for the combined cohort as well as  
stratified samples by prediction level (<10% predicted mortality, 10-50% predicted mortality 
or >50% predicted mortality). A one way analysis that included a bivariate linear regression, 
ANOVA and a Pearson’s correlation analysis was done. A total of 47,982 critical and high  
dependency patients were scored from 1 June 2013 to 31 July 2014. 1921 records (0.4%)  
were excluded due to missing values, duplicate records and values not within parameters and 
46 061 included in the sample.  
Results  
The mean age was 58.8 (95% CI 22-87) years, mean APS score 26.5 (95% CI 4-83) and  
APACHE ®IV score 36.3 (95% CI 9-95). The total crude mortality rate was 7.4%. The models  
correlated moderately when the combined cohort was evaluated (Pearson’s correlation  
Index: 0.62 (95%CI 0.62-0.63 R-squared: 0.38).  The stratified samples showed very good  
correlation for the <10% stratum (Pearson’s correlation Index: 0.88, R-squared: 0.78 95%CI  
0.878-0.882), good correlation for the 10 - 50% predicted mortality rates (Pearson’s  
correlation Index: 0.78, R-squared: 0.61 95%CI 0.77-0.79) and no correlation for the >50%  
predicted mortality stratum (Pearson’s correlation Index: 0.09, R-squared: 0.01 95%CI 0.03- 
0.15).  
Conclusion  
The administrative predictive model correlate well at equal or less to 50% predicted  
mortality rate, while not showing a correlation at high predicted mortality rates (>50%) and is 
not suitable for predicting mortality in the highest stratum.  
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The healthcare industry is facing ever increasing pressure to improve and “prove” the value  
of care provided to patients and funders. [1] Healthcare funders are using proxy  
administrative measures, obtained from accounts submitted to the healthcare funders, to  
extrapolate the quality of care delivered. These measures are used to negotiate tariffs, build  
provider networks and design new service lines.[1] The measurement of mortality as an  
outcome indicator is widely used, as death is seen as an unambiguous variable critically  
important to patients. The actual number of deaths is reported on as the crude mortality  
rate however institutions differ on many fronts and crude mortality rates can’t be directly  
compared.[2] Hospital standardised mortality ratios (HSMR), derived from administrative  
data, has been touted as a simple quality measure that can adjust for the differences  
between patients and allow hospitals to be compared to one another. The HSMR is  
influenced by a number of variables unrelated to the quality of care and doubt has been  
cast on the accuracy thereof. The ability to accurately predict the expected mortality rate  
remains challenging.[2]  
 
Physiological predictive scoring models are believed to more accurately reflect the risk of 
death.[3] Enfield, et al. compared how well predicted mortality rates correlate when  
calculated with an administrative predictive scoring model versus a physiological predictive 
model in critically ill patients. They included 556 patients from two medical centres and found 
that at low predicted mortality rates (<10 %) the models correlated well but diverged at higher 
values. Enfield, et al. also concluded that the use of an administrative predictive scoring model 
is not suitable in critically ill patients.[3]  
The healthcare organisation where this research was performed reports monthly on the  
HSMR for all patients.  Acute Physiology and Chronic Health Evaluation (APACHE® IV) is  
additionally used to score all eligible critically ill patients. However, no research has  
previously been undertaken to compare these two measures. The purpose of this study was 
to compare the administrative predictive scoring model (HSMR) to that of the physiological 
predictive model (APACHE® IV) and to further stratify the patients into different risk samples 
to ascertain the correlation and performance of the models.  
 
Materials and Methods  
Ethics approval was granted by the Research Ethics Committee - University of Cape Town and 
the organisation’s own Internal Ethics Committee. No individual consent was sought as 
de-identified patient data was summarised and used in the analysis.  A cross-sectional study 
design was used to achieve the research objectives.  
The main objective of the study was to ascertain if the predicted mortality rate calculated  
with an administrative model (HSMR) correlated with the predicted mortality rate  
calculated with a physiological model (APACHE® IV) in critically ill patients. The secondary  




severely ill. The cohort was stratified into low (<10 %), medium (10 %-50 %) and high (˃50 
%) predicted mortality rates in keeping with the observed acuity of the patients and in line 
with the strata described in a study by Enfield et al. comparing a proprietary HSMR model  
to APACHE® IV [3] The administrative predictive model  was based on international best 
practice/standard and developed in-house for operational use (detail available on request).  
The Hospital standardized mortality index (HSMI) is defined as the ratio between the actual  
mortalities and the predictive mortalities (or hospital standardized mortalities) based on the  
underlying model used. The data was obtained from the healthcare organisation’s data  
warehouse. The statistical analysis was performed by Mr Jacques de Kock. A one-way analysis 
that included a bivariate linear regression, ANOVA and a Pearson’s correlation analysis was 
done with SAS Enterprise Guide Version 6.1 (Copyright © 2013 by SAS Institute Inc., JMP® 
11.1.1 Statistical Discovery from SAS (Copyright © 2013 by SAS Institute Inc.) and Microsoft 
Excel™ 2010 (Copyright© 2010 by Microsoft Corporation. 47,982 records were captured and 
scored across 40 hospitals and 68 Critical Care Units. Of these records, 1,921 (04%) were 
excluded due to missing values, values not within parameters and duplicate records and 
46,061records included in the sample for analysis.  
Data were included for critically ill patients admitted to Mediclinic, a private acute care 
hospital group, in South Africa for the time period 01 July 2013 to 30 June 2014.  All patients 
classified as critically ill, including high dependency patients, and admitted to a critical care 
unit were considered for inclusion. Patients were scored on the Clinical Criteria checklist and 
classified into intensive care, high dependency or general ward according to the score 
obtained. The clinical criteria scoring system was developed within the healthcare 
organisation in the late nineties with input from the healthcare funders. The objective was to 
create a standardised platform for ‘level-of-care’ (LOC) billing. The charging of LOC is based 
on the complexity of care (human resources required as well as the required environment) 
and internal and BHF billing guidelines. More information on the clinical criteria scoring 
system is available on request.  
All patients admitted to intensive and high dependency units that met the entry criteria for  
APACHE® IV were included. Patients who had temporarily received specialised care in  
general wards due to CCU bed unavailability were also included in the cohort. The database  
exclusion rules were followed in selecting eligible patients: patients younger than 16 years,  
patients admitted with burns, patients admitted with chest pain in order to rule out acute  
myocardial infarction (AMI) and patients with a critical care unit (CCU) stay of less than 4  
hours were excluded. There were no standard data collection processes and the unit  
manager, allocated nurse, nursing shift leader or data capturers collected the data as part of  
daily responsibilities.  
Pre-printed forms were used to collect the data. The data collection was done after  
discharge from CCU or after admission to the CCU for more than 24 hours. The mid-points of  
the physiological variables were indicated on the data collection forms. This decreased the  




identifiable patient information was captured and only the visit number recorded. The data  
was subsequently transferred to an electronic, in-house developed application to enable  
secure storage of information (for data warehousing) and reporting. All responsible staff  
was trained early in 2013 as the organisation transitioned from the third version of  
APACHE® to the fourth. A comprehensive, internally developed e-learning module was also  
freely available to all staff.  
 
Predictive scoring models  
SMR (Physiological data)  
APACHE® IV was chosen as it is routinely used as a quality measure by all CCU’s in the  
healthcare organisation.  APACHE ® IV was developed in the United States of America (USA)  
and the attributes of the model are well documented in the peer reviewed literature.[4] The  
attributes of the patient population that is admitted to the CCU’s in the healthcare  
organisation may differ substantially from the original reference population of the model  
however the model was not recalibrated for local use. The version of APACHE® IV that is  
freely available on the internet was used to create an electronic database and the  
information was extracted from the data warehouse.  The way in which the study was  
conducted may improve the external validity however calibration of the model for future  
use is desirable. [4]  
SMR (Administrative data)  
The HSMR model was developed in 2007 and last updated in 2009.  Death is treated as a  
binary response variable and a logistic regression model used to adjust for differences in  
case-mix in order to calculate an expected mortality rate per admission. The algorithm  
identifies the driver code on the account from routinely collected demographic data,  
diagnostic codes (ICD-10) and procedural codes (CPT4).  A number of patient level risk  
factors are also taken into account: age, gender, comorbidities, primary and secondary  
diagnosis, procedure performed and treating speciality. HIV was not coded in the healthcare  
organisation until mid-2010.  This was due to the description of the ICD-10 code that was  
printed on the account impacting on patient confidentiality. The incomplete coding of the  
care episode resulted in the healthcare organisation having little background data to analyse  
and assign a weight to HIV.  With the update of the HSMR model in 2009 the ICD-10 code  
‘B33.3’ was used as a proxy to indicate the possible presence of HIV.  Since mid 2010  
descriptions of ICD-10 codes are no longer printed on the account and the coding of HIV in  
line with industry standards is encouraged.  The HSMR is routinely calculated for all in- 
patients however only records from corresponding patients included in APACHE® IV were  








Data integrity  
APACHE® IV  
The quality of the data entered was evaluated by informal audits and quality control  
measures.  To ensure that patients eligible for inclusion weren’t missed, a detailed analysis  
of compliance was done. A compliance report compared patients flagged as ‘critical care’  
based on billing criteria to database entries to ensure that no patients were missed. Further  
information of fields left blank and marked as ‘not available’ was sought and if none could  
be found it was included in the model as normal values. A maximum of 12 fields could be 
marked as “not available” and an average of 6.7 fields per entry was marked as not available.  
The number varied amongst the hospitals and the number of “not available fields” entered 
was much higher in high care patients.  The blood gas results were most often omitted. The 
integrity of the data contained in the warehouse was validated monthly. Where data was 
submitted to the database but the application didn’t calculate a score, the records were 
re-scored and included in the set. In cases where some of the information was unavailable 
the records were excluded from the calculations. If a duplicate record was captured the first 
record was included and subsequent copies excluded.  
HSMR  
All files of deceased patients were audited by staff trained in clinical coding. This procedure  
was followed to ensure that the clinical and procedural coding accurately reflected the  
clinical care episode. Any incomplete or incorrect coding was rectified and updated in the  
warehouse. Additional information was sought from treating doctors where appropriate.  
The healthcare organisation has a structured audit process in place and clinical and  
procedural coding is audited quarterly. During the audits a random representative stratified  
sample is obtained per hospital with a further sample of these files subjected to an ‘audit- 
of-the-auditor’ process.  The audits focus on missed or incorrect codes: ‘primary diagnosis,  
secondary diagnosis, comorbidities and procedures’ as well as the correct sequencing of  
codes.  
Results  
The mean age of the patients was 58.8 (95%CI 22-87), mean APS score 26.5 (95%CI 4-83)  
and mean APACHE ®IV score 36.3 (95%CI 9-95). The split between male and female was  
almost even with 51.9% males. The predicted mortality rate was 3.4% in the administrative  
and 6.2% in the physiological model. The crude mortality rate for the cohort was 7.4% (n = 3  
400).  (Table 1)  
The comparison between HSMI for models using patient administrative data versus patient  








A relatively average positive linear fit between these (Pearson’s correlation Index:  
0.62 95%CI 0.62 -0.63, R-squared: 0.38) was found. Table 2 and figure 1 describe the 
bivariate fit of the HSMI physiological model versus the administrative model.  
The data from the physiological model was ranked and grouped into quintiles according to  
the HSMR and was then compared to the administrative models for the corresponding 
quintiles.  It was found that the total predicted mortality cases for the administrative model  
were higher than the total predicted mortality values for the physiological model, as well as  
the actual number of mortalities in each of the first three quintiles. In the fifth quintile the 
opposite was noticed and in the fourth quintile, the actual and predicted total mortalities 
for each model were relatively similar. (Figure 2)  
A similar effect to dividing the sample in quintiles can also be realised when categorizing the  
predicted mortalities according to the following strata: ‘<10% predicted mortality, 10 - 50%  
predicted mortality and >50% predicted mortality’ as illustrated in figure 3. The bivariate fit  
shows that the performance of the administrative and physiological models at low predicted  
mortality rates (<10%) is similar as illustrated in figure 4. At 10-50% predicted mortality rate  
there was a good correlation between the models (Pearson’s correlation Index: 0.78 95%CI  
0.77-0.79, R-squared: 0.61) and 10 - 50% predicted mortality both the administrative as 
well as the physiological model seemed to underestimate the predicted mortality rates 
however the physiological model performed better. (Figure 5)  
The  bivariate fit illustrated  that there was a difference between the total predicted  
mortality for the two models at high predicted mortality rates (sample size n = 1 195 for 38  
hospitals), as well as no significant correlation (Pearson’s correlation Index: 0.09, R-squared:  
0.01 95%CI 0.03-0.09 ) when the high predicted mortality stratum values are compared to one 
another. In the high predicted mortality stratum (>50%) the mortality prediction by the 
administrative model differed significantly from the physiological model and greatly  
underestimated the predicted mortality rate.  The predicted mortality rate with the  
administrative model also decreased as the acuity increased. These findings are illustrated in 














The findings of our study supported the findings of Enfield et al. in that the two models did  
not correlate well at high predicted mortality rates. Contrary to the existing literature, we  
found that the administrative and physiological predictive models both correlated well with  
predictions for predicted mortalities 10 - 50%. The administrative model greatly  
underestimated the predicted mortality in the highest stratum.[3] In most of these cases  
there was a better fit to the actual mortalities using the physiological model rather than the  
administrative model, but more noticeably the administrative model is not adequate to  
model mortalities in the fifth quintile. This may be due to a lack of information on the  
patient’s physiological condition which may be necessary to predict mortality outcomes. A  
study by Shahian et al. illustrated that there were marked variability amongst proprietary  
mortality prediction models and the predicted mortality rate varied greatly when calculated  
with different proprietary mortality prediction models and applied to the same cohort. [5]  
In our study the models correlated moderately well when the cohort was considered as a  
whole and not stratified.  This may have been due to the inclusion of a large number [n = 28  
516] of high dependency patients in the cohort. These patients were never categorised as  
critical care patients and have low predicted mortality rates that may skew the data. This 
finding was also reflected in the observed mortality rates which were 18.1% in the study by  
Enfield et al. and 7.4% in our study. [3] The accuracy of diagnostic and procedural coding is  
very important in the administrative model and the outliers may suggest hospitals with  
some degree of incorrect coding or incorrectly captured information. Outliers in the HSMI is 
especially evident in the >50% predicted mortality rate band (figure 6 ) where the bulk of the 
HSMI values is in the 5-15 range as calculated with the administrative model.  This doesn’t 
correlate at all with the HSMI for the corresponding values calculated with the physiological 
model (HSMI values 0.8 – 1.4). The HSMI for the administrative model consistently had higher 
indices (p-value < 0.0001) than the HSMI for the APACHE® IV model and this may have been 
due to critical care patients only forming a subset of the inpatient data that was used to build 
the model. The model may have only marginally adjusted for critical care patients and 
consequently underestimated the predicted mortality values. It follows that the 
administrative model is not a good predictor for tail end outlier cases, whereas the 
physiological model almost accurately predicted the correct number of mortalities in the 
highest stratum. The HSMR administrative model was not recently updated however the 
model will be updated in the near future and the addition of more variables may improve the 










There were a number of other limitations to the study.  The APACHE®IV model wasn’t  
calibrated for the cohort and there may have been other variables, not related to the  
model, which influenced the outcome. The burden of disease of HIV is large in Southern  
Africa and even though the study was conducted in a private healthcare group this may  
have had a major influence on the results. [6] The APACHE®IV model may not sufficiently  
risk adjust for HIV. The decentralised role out of antiretroviral therapy (ART) in the public  
sector has reduced the mortality rates of HIV substantially over the last decade. [6] The  
previous administrative invoicing practice in the healthcare organisation leading to HIV not  
being coded until mid 2010 may have influenced the predicted mortality rates. The manual  
data collection for APACHE ®IV as well as the informal audit process in validating the data  
accuracy may all impact on data quality. The clinical criteria score was developed in line with  
international best practice however may still have introduced bias.  
 
Conclusion  
The HSMR (administrative model) is a relatively easy and inexpensive means of calculating  
predicted hospital mortality ratios in all but the highest risk-group. The model show good  
correlation at 50% and less predicted mortality rates.  However in patients with a high  
predicted mortality, >50%, the administrative model is inadequate in predicting the  
expected mortality rate. This may lead to a high mortality index in hospitals that offer more  
specialised care and have a higher case-mix that is due to the characteristics of the model  
and not related to poor quality of care.  
 
The physiology model (APACHE®IV) more accurately predicted the outcome of patients in the 
highest stratum and a physiological model may be more suitable in this subset of patients.  
The inclusion of high dependency patients in the cohort may dilute the index and the 
suitability of the model in this population needs to be further investigated. The healthcare 
industry is searching for accurate, inexpensive and simple clinical outcome measures to 
gauge their performance, the value delivered to patients, and support quality improvement 
initiatives.  Healthcare funders are looking for similar measures to gauge the value that is 
delivered to their members.  The results of this study highlight the limitation of the current 
















Key Points  
   The HSMR (administrative model) is comparable to the physiological model in  
predicting mortality rates in less ill patients (<10% predicted mortality), correlates 
moderately well in 10 -50% predicted mortality and may offer an inexpensive, easily 
computational model to predict mortality rates in these groups  
     As the predicted mortality rate increases, the models diverge and show poor    
correlation at high (>50% predicted mortality) rates.  The physiological model also  
more accurately predicts the mortality rate in the middle group (10 - 50% predicted  
mortality rate) however not as well as in the high predicted mortality group  
 The physiological model (APACHE®IV) more accurately predicted mortality rates in  
 critically ill patients however only the predictions from this model has been taken  
 into consideration and it may not hold true for other models  
 Ideally the physiological model needs to calibrated for the population it will be used  
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Figure titles and legends  
Figure 1 Bivariate fit of HSMI  
Bivariate fit of the HSMI for the physiological model versus the administrative model  
Figure 2 Distribution plot by quintiles  
Distribution plot of the number of mortalities as well as the predicted mortalities grouped 
by each quintile  
Figure 3 Distribution plot by predicted mortality categories  
Distribution plot of the number of mortalities as well as the predicted mortalities group by 
predicted mortalities categories  
Figure 4 Bivariate fit of the HSMI for predicted mortalities <0.1  
A bivariate of the HSMI for the physiological model versus the administrative model only for 







Figure 5 Bivariate fit of the HSMI for predicted mortalities 0.1-0.5  
A bivariate of the HSMI for the physiological model versus the administrative model only for 
predicted mortalities 0.1- 0.5 as observed in the physiological model  
Figure 6 Bivariate fit of the HSMI for predicted mortalities >0.5  
A bivariate of the HSMI for the physiological model versus the administrative model only for 















Number of records 46 061 
 
Mean Average Age in Years [with 95% C.I.] 58.8 [22; 87] 
 
Gender Split (% Male) 51.9% 
 
Cases Ventilated (%) 6.8% 
 
26.5 [4; 83]  
Mean Average APS Score [with 95% C.I.]  
 
 
36.3[9; 95]  
Mean Average APACHE® IV Score [with 95% C.I.]  
 
 
Number of Mortalities (with rate) 3 400 (7.4%) 
 
Predicted Mortalities - Administrative Model (with rate) 1 581 (3.4%) 
 
































































































































































































































































































































Table 2 Bivariate fit of the HSMI physiological model versus the administrative model 
Linear Fit  
HSMI (Physiological model) = 0.6485635 + 0.2524353*HSMI (Administrative Model)  
Summary of Fit  
RSquare 0.382442 
RSquare Adj 0.366191 
Root Mean Square Error 0.270484 
Mean of Response 1.188491 
Observations (or Sum 40 
Wgts) 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio 
Model 1 1.7216926 1.72169 23.5327 
Error 38 2.7801466 0.07316 Prob>F 
C. Total 39 4.5018392 <.0001 
Parameter Estimates 
Term Estimate Std Error T Ratio Prob>[t] 
Intercept 0.6485635 0.119235 5.44 <.0001 
HSMI (Administrative 0.2524353 0.052037 4.85 <.0001 
Model) 
Correlation 
Variable Mean Std Dev Correlation Signif. Prob Number 
HSMI (Administrative 2.138875 0.83233 0.618419 <.0001 40 
Model) 
HSMI (Physiological Model) 1.188491 0.339753 
  
 









Mean Average Age in Years (with 95% C.I.) 
 
Gender Split (% Male) 
 
Cases Ventilated (%) 
 
Mean Average APS Score (with 95% C.I.) 
 
Mean Average APACHE IV Score (with 95%  
C.I.) 
 
Number of Mortalities (with rate) 
 
Predicted Mortalities - Administrative 
Model (with rate) 
Predicted Mortalities - Physiological Model 
(with rate) 
                
                                                                                  
                 
Cases included in   Cases included in   Cases included  
Strata 1*  Strata 2*  in Strata 3* 
 
39,848 5,018 1,195 
 
57.8 65.6 62.3 
[22; 86] [28; 91] [27; 89] 
 
51.9% 51.6% 52.8% 
 
2.3% 27.8% 68.4% 
 
21.2 38.4 33.3 
[4; 51] [5; 126] [6; 90] 
30.5 49.0 44.0 
[7; 65] [10; 140] [11; 102] 
 
465 (1.6%) 1,522 (26.3%) 1,413 (12.0%) 
 
722 (2.5%) 311 (5.4%) 548 (4.7%) 
 





















2,853 (6.2%)  
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Table 4 Bivariate fit of the HSMI physiological model versus the administrative model (only for predicted mortalities 
less than 0.1 observed in the physiological model)  
Linear Fit  
HSMI (Physiological model) = 0.10572 + 1.3612494*HSMI (Administrative Model)  
Summary of Fit  
RSquare 0.781508 
RSquare Adj 0.775759 
Root Mean Square Error 0.292594 
Mean of Response 1.023298 
Observations (or Sum Wgts) 40 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio 
Model 1 11.636257 11.6363 135.9197 
Error 38 3.253228 0.0856 Prob>F 
C. Total 39 14.889484 <.0001 
Parameter Estimates 
Term Estimate Std Error T Ratio Prob>[t] 
Intercept -0.10572 0.107324 -0.99 0.3308 
HSMI (Administrative Model) 1.3612494 0.116761 11.66 <.0001 
Correlation 
Variable Mean Std Dev Correlation Signif. Prob Number 
HSMI (Administrative Model) 0.829399 0.40127 0.88403 <.0001 40 
HSMI (Physiological Model) 1.023298 0.617885 
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Table 5 Bivariate fit of the HSMI physiological model versus the administrative model for predicted mortalities between  
0.1 and 0.5 and observed in the physiological model  
Linear Fit  
HSMI (Physiological model) = 0.5886158 + 0.1834806*HSMI (Administrative Model)  
Summary of Fit  
RSquare 0.611485 
RSquare Adj 0.601261 
Root Mean Square Error 0.269106 
Mean of Response 1.417116 
Observations (or Sum Wgts) 40 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio 
Model 1 4.3312134 4.33121 59.8084 
Error 38 2.7518906 0.07242 Prob>F 
C. Total 39 7.0831039 <0.0001 
Parameter Estimates 
Term Estimate Std Error T Ratio Prob>[t] 
Intercept 0.5886158 0.115271 5.11 <0.0001 
HSMI (Administrative Model) 0.1834806 0.023725 7.33 <0.0001 
Correlation 
Variable Mean Std Dev Correlation Signif. Prob Number 
HSMI (Administrative Model) 4.515468 1.816278 0.781975 <0.0001 40 
HSMI (Physiological Model) 1.417116 0.426167 
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Table 6 - Bivariate fit of the HSMI physiological model versus the administrative model for predicted mortality rate >0.5 
and observed in the physiological model  
Linear Fit  
HSMI (Physiological model) = 1.0990239 + 0.004246*HSMI (Administrative Model)  
Summary of Fit  
RSquare 0.007489 
RSquare Adj -0.02008 
Root Mean Square Error 0.174238 
Mean of Response 1.134941 
Observations (or Sum Wgts) 38 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio 
Model 1 0.0082470 0.008247 0.2716 
Error 36 1.0929202 0.030359 Prob>F 
C. Total 37 1.1011672 0.6054 
Parameter Estimates 
Term Estimate Std Error T Ratio Prob>[t] 
Intercept 1.0990239 0.074484 14.76 <0.0001 
HSMI (Administrative Model) 0.004246 0.008146 0.52 0.6054 
Correlation 
Variable Mean Std Dev Correlation Signif. Prob Number 
HSMI (Administrative Model) 8.459164 3.516185 0.086541 0.6054 38 
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CLINICAL CRITERIA FOR  
 SPECIALISED UNITS 
 
REPORT ON WORST CASE SCENARIO IN LAST 24 HOURS AUTHORISATION (I hereby certify that mentioned must be admitted to) 
 
Signature 
PATIENT STATUS Level of Care Level of Care Movement 
 
Specialised Critical Care 
* * * Specialised Critical Care Date Time Date Time 
 















 To  : 
 
: 
Three (3) Ticks without *** or ** or *   : 
 
: 
COMORBIDITIES Critical Care Date Time Date Time 
 
Chronic Iscaemic Heart Disease  Asthma  From  : 
 
: 
Unstable Angina  Obesity BMI> 30  To  : 
 
: 
Hypertension  Chronic Arterial Fibrilation/Flutter  Ventilator: From  : 
 
: 
Hyperthiriodism  Epilepsy  To  : 
 
: 
Hypercholesterolaemia      : 
 
: 
Diabetes (Insulin dependent)    High Care Date Time Date Time 
 
Diabetes (Non-Insulin dependent)    From  : 
 
: 
Chronic Renal Failure    To  : 
 
: 
Congestive Heart Failure    Monitor: From  : 
 
: 
Hyperlipidaemia    To  : 
 
: 
Chronic Obstructive Pulmonary Disease 




REVISED 30.05.2013 dcprinters.co.za 
© COPYRIGHT MEDICLINIC  = present; IV = Intravenous 
CL 2416  
103 
 
Report on worst case scenario in previous 24 hours Report on worst case scenario in previous 24 hours  
Date        Date        
RESPIRATORY SYSTEM NEUROLOGICAL SYSTEM 
Respiratory arrest within 24 hours **        Glasgow coma scale 8 **        
Mechanically ventilated with FiO²  _ .6% **        Glasgow coma scale 9 - 12 *        
Mechanically ventilated **        Glasgow coma scale 13 -14        
Noninvasive Positive Pressure Ventilation **        Raised intra cranial pressure *        
Extubated <24 hours **        Status Epilepticus **        
Intubated but not ventilated **        Occurrence of seizures in last 24 hours        
Oxygen O  > 40% * 
² 
       Ventricular drain **        
Saturation <90% on O²  _ 40%*        Polyuria        
Respiratory acidosis *        Brain / Spinal surgery        
Respiratory alkalosis *                
Respiratory rate >30 per minute *        RENAL SYSTEM 
Bronchospasm / Stridor *        Serum creatinine 1.5 x baseline OR 
Urine output <0.5ml/kg x 6 hr * 
       
<2 hourly nebulisations               
<2 hourly suctioning        Serum creatinine 2 x baseline OR 
Urine output <0.5ml/kg/hr x 12 hr * 
       
Tracheostomy               
CARDIO VASCULAR SYSTEM Serum creatine 3 x baseline OR 
Urine output <0.3ml/kg/hr x 24 hrs OR 
Anuria x 12 hrs ** 
       
Cardiac arrest within 24 hours **               
Sternotomy <24 hours ***               
Acute MI + Trop I/T **        Acute renal dialysis **        
Angina *        Chronic renal failure *        
Ischaemic ECG changes *        Metabolic acidosis *        
PTCA ** / Stent ** <12 hours        Metabolic alkalosis *        
Ablation * / Rotablator * <24 hours                
Acute Dysrhythmia *        OTHER 
Elective Cardioversion < 12 hours *        Major blood transfusion **        
Temporary Pacemaker-dependent **        Autotransfusion *        
Perm. Pacemaker- post insertion 12 - 24 hrs *        Epidural *        
Vasopressor / Positive Inotrope dependent **        Post-operative monitoring * 24 - 48 hours        
Vascular Stent <12hours**        Cont. Invasive/non-invasive monitoring 
_ 4 hours every 15-30 minutes ** 
       
Hypovolaemia *        
Tachycardia        Pyrexia >38.3°C        
Bradycardia        Subnormal temperature <35.5°C        
Hypotension                
Hypertension                
Increased capillary leak with edema                




Report on worst case scenario in previous 24 hours Report on worst case scenario in previous 24 hours  
Date        Date        
MEDICATION IVI MONITORING / INVASIVE LINES 
Positive inotropic support **        ICP monitor 1st 24 hours ***        
Anti-dysrhythmics **        ICP monitor >24 hours **        
Platelet aggregation inhibitors *        PA catheter **/ Atrial line **        
Fibrinolytics **        Sheath post angiogram <12 hours **        
Insulin *        IABP **        
Sedation **        A-line *        
Vasodilators ** / Vasopressor **        Central Venous O  saturation monitoring * 
² 
       
Muscle relaxants **        Noninvasive cardiac output monitor        
Ca Channel blockers **        CVP line        
Diuretics        Acute dialysis catheter        
TPN                
Opioids *        EMERGENCY PROCEDURES WITHIN 24 HOURS 
Precedex ©*        Transvenous pacing **        
        Transcutaneous pacing **        
LABORATORY IMBALANCES Intubation **        
Hypo Serum Na 130 mmol/l *        Emergency Tracheostomy **        
Hyper serum Na _ 150mmol/l *        Pericardial tap 1st 24 hours **        
Hypo serum K+ *        Emergency Cardioversion **        
Hyper serum K *        Defibrillation **        
Hypo serum glucose *        Intercostal drains        
Hyper serum glucose                
Increased serum osmolarity *                
Raised Bilirubin        Intravenous Medication with ** Date Start Time Start Date Stop Time Stop 
Acute Hb <8gr/dl/L *          :  : 
Raised cardiac markers *          :  : 
Abnormal high levels of therapeutic medication **          :  : 
Toxic levels of medication **          :  : 
Platelet counts 100 *          :  : 
Abnormal INR          :  : 
Positive DIC Screen **          :  : 
Ph 7.20 **          :  : 
Raised serum amylase *          :  : 
Albumin < 20 *          :  : 
          :  : 
          :  : 
 = present  
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INTRAVENOUS MEDICATION KEY ORGAN FAILURE 
Positive Inotropic Agents eg. Dobutamine, Dopamine, Digoxin, Adrenaline Respiratory System  : Mechanically Ventilated with FiO _ .6% 
² 
Anti-dysrhythmics eg. Amiodarone, Lignocaine, Adenosine Cardiac System : Vasopressor Dependent 
Vasodilators eg. Tridil ®, Isoket®, Nitrocine®, Trandate Renal System : Acute Renal Dialysis 
Platelet Aggregation Inhibitors eg. Aggrastet®, Integrillin®, Reopro® Haematology : Positive DIC Screen 
Vasopressors eg. Adrenaline, Noradrenalin, Phenylephrine MAJOR BLOOD TRANSFUSION 
Fibrinolytics eg. Actilyse®, Metalyse®, Streptase® Definition: Major blood transfusion is the replacement of the total blood 
Muscle Relaxants eg. Nimbex®, Pavulon®, Scoline® volume within 24 hours 
 
Sedatives and Opioids 
eg. Sublimaze®, Ultiva®, Rapifen®, Sudenta, Tramadol, Dormicum®, Diprivan®, 
Morphine, Pethidine, Precedex® 
Formula: Total blood volume = 70ml blood/kg body mass 
(total weight 
Calculation: 70ml (blood) x kg = ml(total blood of patient) volume) 
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The purpose of the Clinical Criteria for Specialised Units form is to determine the correct level of care for a specific patient, according to 
the patient‟s condition.  
It also serves as a tool to obtain accurate coding information.  
The correct level of care and the coding information is used in the case management process in the hospital.  
 
Scope  
This form is completed by the CCU nursing staff and the information gathered is used by the Case Coordinator in the hospital, for 
updating clinical information and for negotiations with medical funds.  
 
Background  
Previously, level of care was determined on the grounds of the amount of nursing input required for a patient.  This method proved  
inaccurate and it was decided that the patient‟s condition would serve as a better indicator as to what level of care a patient  
requires.  
 
About the Form  
In this document the form and its content will be described in general.  Specific keys are used to guide the user through the 
interpretation of the form.  
 
Important  
The criteria are not used on patients in normal wards to determine if they should be send to a specialised unit.  Only after the 
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Sections on the form  
The form is divided into the following sections/tables (Each of these will be discussed separately later in this document):  
 Comorbidities  
LOC (Level of Care) Movement (date and time) 
Respiratory System indicators  
Cardio Vascular System indicators  
Neurological System indicators  
Renal System indicators  
Other  
Medication IVI  
Laboratory Imbalances  
Monitoring/Invasive lines  
Emergency Procedures  
IVI Medication with **  
Additional Notes  
For how many days does the form provide?  
The form can be used for a period of seven (7) days per patient, after which a new form must be completed.  Date columns are 
provided for each section of the form.  
As always, the previous days‟ information is indicated on today‟s date, and the worst scenario of the last 24 hours is indicated on the  
form.  
 
What is the standard method of ticking off the indicators/conditions?  
A normal tick (  ) is placed next to every indicator/condition the patient conforms to for that specific day.  
 
What if the patient has a condition that does not appear on the form?  
With the exception of the Comorbidities columns where extra lines are provided for additional entries, the rest of the sections were 
carefully designed to only include those conditions that would have an effect on the level of care.  
Note that diagnosis was deliberately excluded, since it‟s not an accurate indication of the required level of care.  
 
How do I interpret the keys?  
The keys used on the form are *, ** and ***.  These keys can be found next to specific indicators/conditions and indicate whether 
the patient should be in HIC, CCU or SICU.  Some conditions do not have any key next to it.  Besides the keys itself, the number of 
ticks also serves as an indication of what level of care the patient should occupy.  
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Sections on the Form  
Each section will be discussed separately.  
Only the sections and the indicators that need some discussion will be elaborated on with regards to definitions and circumstances.  
 
Comorbidities  
The 15 most frequently reported comorbidities (according to Mediclinic coding statistics) were listed here.  Additional lines were 
added to provide for extra comorbidities to be listed if necessary.  
 
Comorbidity Description 
Hyperlipidaemia Hyperlipidaemia refers to high blood cholesterol or high blood triglycerides 
Hypercholesterolaemia Hypercholesterolemia refers to high blood cholesterol 
 
 
Patient Status  
In this section we indicate the patient‟s level of care movement by completing the dates and times at which a patient moved into 
and out of a specific unit.  This section should be completed extremely accurately.  
Provision is also made for indicating the date and time periods when a patient was ventilated.  
This information can be used to check whether or not the patient must still be in a specific unit.  
 
Other Important Info  
Additional lines have been provided to include information unrelated to comorbidities, but which has clinical relevance. Examples 
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Respiratory System  
Please note the following indicators/conditions in this section:  
 
Indicator Description 
Mechanically ventilated with FiO₂ Indicates that this patient is in a type 2, 3 or 4 respiratory failure according to the P/F ratio 
> .6** >200. 
NPPV** 
Non-Invasive Positive Pressure 
Ventilation 
NPPV is the delivery of mechanically assisted or generated breaths without placement of an  
artificial airway.  Both CPAP and BiPAP are considered as NPPV. Significant percentages of 
patient who receive this modality are acutely ill or have severe underlying disease. The patient 
does not have to be continuously ventilated non-invasively; it can just be for short periods at a 
time when not coping without ventilatory support.  
Extubated < 24 hrs **  Patient should be in CCU for up to 24 hours post extubation.  Not all extubations are  
successful, and the patient must be monitored for up to 24 hrs for possible re-intubation  
Intubated but not ventilated **  This patient has an endotracheal tube in place, but is not ventilated.  This is often to maintain  
an open airway and help reduce the risk of aspiration.  The patient will require suctioning and  
close monitoring to prevent complications  
Oxygen >40% *  Oxygen therapy per mask greater than 40% or oxygen therapy via nasal cannula (> 5 LPM)  
Saturation < 90% on O₂  > 40% * Indicative of hypoxia despite oxygen therapy and may indicate impending respiratory failure. 
Respiratory acidosis * This is going to require PN interpretation. 
A respiratory acidosis is a pCO2 > 6.1 KPa (irrespective of compensation).  It indicates 
decreased gas exchange  
Respiratory alkalosis * This is going to require PN interpretation. 
A respiratory alkalosis is a pCO2 < 4.6 KPa.  There are multiple causes and often it is a 
compensatory response to metabolic acidosis  
Respiratory rate > 30 bpm*  There are increased oxygen demands and the respiratory rate increases in order to meet this  
demand.  It is indicative of underlying problems and the patient requires close monitoring  
(HICU at least)  
Bronchospasm / Stridor*  These are symptoms of airway obstruction.  Patients are at risk for impending respiratory  
failure  
< 2 hourly nebulisations This is applicable to patients in acute bronchospasm (usually an acute asthma attack) 
< 2 hourly suctioning  When the patient is being suctioned more frequently than 2 hourly.  This is mostly applicable  
to a non-intubated patient who has difficulty maintaining their airway.  This is not suctioning  
of the mouth but rather oro/naso-pharyngeal suctioning to clear secretions and keep the  
airway patent  
Tracheostomy  Note the difference between a Tracheostomy in this section versus a Tracheostomy in the  
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Cardio Vascular System  
Please note the following indicators/conditions in this section:  
 
Indicator Description 
Cardiac arrest within the 1st 24 hours**  If the patient had cardiac arrest, the patient should be in CCU for at least the 1st 24  
hours.  
Sternotomy within 24 hours *** This indicator refers to any heart and lung surgery viewed as „open heart‟ surgery. 
Acute MI < 24 hours with + Trop I/T**  The cardiac markers Troponin T or I are positive indicative of a myocardial infarction,  
irrespective of whether the patient has had an ST-elevation myocardial infarction  
(STEMI) or a non-ST elevation myocardial infarction (NSTEMI).  
Angina *  Angina is classified as stable or unstable.  Unstable angina is chest pain at rest, and  
indicates partial clot formation in a coronary artery causing decreased blood supply to  
the heart muscle.  This decreased blood supply results in „chest pain‟ as a symptom.  
PTCA** / Stent ** < 12 hrs  The patient status is CC due to the nature of the procedure and / or the presence of a  
foreign body.  Percutaneous coronary intervention (PCI) includes balloon angioplasty 
with or without placement of a stent.  A PTCA is invasive enough to warrant CC  
monitoring.  Potential complications include thrombosis and haemorrhage  
Acute Dysrhythmia* Please note that this include ALL ACUTE Dysrhythmias. 
CHRONIC Dysrhythmia is NOT INCLUDED unless a Chronic Dysrhythmia becomes ACUTE. 













Temporary pacemaker-dependent ** 
Note on the difference between the cardioversion indicated in this section, and the 
Cardioversion indicated under Emergency Procedures of which the latter will require CC. 
It is most commonly done for atrial fibrillation, atrial flutter and ventricular tachycardia 
(with a pulse).  Elective cardioversion is electrical cardioversion (also known as direct - 
current or DC cardioversion). 
A dysrhythmia can also be chemically cardioverted (for example with Amiodarone). 
Elective cardioversion is a procedure whereby a synchronized electrical current (shock) is 
delivered through the chest wall to the heart through pads or paddles that are applied to 
the skin of the chest and/or back.  The purpose of the cardioversion is to interrupt the 
abnormal electrical circuit(s) in the heart and to restore a normal heartbeat. 
This is going to require the PN interpretation. 
The temporary pacemaker is external and prone to the development of problems.  This is 
usually only a temporary measure until the underlying problem is resolved or a PPM is 
inserted.  The patient must be PM dependent i.e. they do not have an adequate cardiac 
output without the PM.  
Perm. Pacemaker - post insertion 12 -24 Note that the patient status is High Care following the insertion of a PM.  This is 
hrs * necessary for monitoring of potentially life threatening complications, which include the 
development of a pneumothorax, dysrhythmias and haemorrhage. 
Vasopressor/Positive Inotrope Note on the fact that the patient must be TOTALLY DEPENDENT.  This is the indication for 
dependent ** cardiac failure.  The patient can be dependent on vasopressors or positive inotropes to 
maintain an adequate cardiac output (see list of drugs on the last page of the last page of the 
clinical criteria document).  
Vascular Stent < 12 hrs **  ANY other vascular stent falls under this category.  This would include coronary, aortic,  
carotid and cerebral stents.  Patient requires close monitoring because of the possibility of 
developing acute thrombosis or haemorrhage which would be life threatening.  
Hypovolaemia *  This is going to require the PN interpretation.  
A dramatic reduction in circulating volume as a result of the patient‟s underlying 
condition.  Symptoms include an elevated pulse rate, diminished blood pressure and 
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 signs of decreased perfusion (poor capillary refill, weak peripheral pulses) 
Tachycardia Pulse rate > 100 bpm (in adults) 
Bradycardia Pulse rate < 60 bpm (in adults) 




Neurological System  
Please note the following indicators/conditions in this section:  
 
Indicator Description 
Glascow coma scale < 8** Patient usually not able to maintain or protect their own airway 
Gloscow coma scale 9 - 12* Patient can usually protect their own airway, but needs constant monitoring 
Glascow coma scale 13 - 14 Patient usually just confused / disorientated 
Raised intracranial pressure* According to the Monro-Kellie Hypothesis, the cranial compartment is incompressible  
and the volume inside the cranium is fixed.  The cranium and its constituents (blood, CSF  
& brain) create a state of equilibrium.  If there is any increase in volume in one of the 
cranial constituents, it must be compensated by a decrease in volume of another. 
Normal ICP is 0-15mmHg.  An ICP > 20mmHg can crush brain tissue, shift brain 
structures, contribute to hydrocephalus, cause the brain to herniated and restrict blood  
supply to the brain.  Following a cardiac arrest, a patient can have a resultant hypoxic  
brain injury.  The hypoxic injury results in cerebral vasogenic oedema and is likely to 
result in raised intracranial pressure.  
Ventricular drain **  An intraventricular drain can be inserted into one of the lateral ventricles for diagnostic  
or intracranial pressure relief purposes.  Once placed, the catheter can be connected to a  
transducer for continuous pressure monitoring or to an external collection system for  
drainage.  
Polyuria  Defined as a urine output > 3L/day.  Needs to be considered if the urine output >  
200ml/hr for 2 consecutive hours.  The clinical history is very important to correlate this as a 
true sign.  This is going to require the PN interpretation.  
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Renal System  
Please note the following indicators/conditions in this section:  
The first 3 indicators are based on the RIFLE criteria (Journal of Intensive Care Medicine 22(4); 2007) for acute renal dysfunction (ARD). 
The Rifle classification defines 3 grades of increasing severity of ARD as Risk (R), Injury (I) and Failure (F). The MOST severecriteria is the 
one that should be selected - i.e. if the serum creatinine is 2 X baseline, but the urine output was < 0.5ml/kg/hr X 6hrs (and not 12hrs), 




Serum Creatinine  1.5 X baseline  OR Indicates Risk (R) of renal failure according to the RIFLE criteria (see above). 
Urine output < 0.5ml/kg/hr X 6hrs * 
Serum Creatinine  2 X baseline  OR Indicates Injury (I) to the kidneys according to the RIFLE criteria and patient is at high risk 
Urine output < 0.5ml/kg/hr X 12hrs * for the development of acute renal failure. 
 
Serum Creatinine 3 X baseline  OR Indicates Renal Failure (F) 
Urine output < 0.3ml/kg/hr X 24hrs 
ORAnuria  X 12 hrs **  
Acute renal dialysis **  This refers to continuous or intermittent routine cycles of hemodialysis, irrespective of  
mode (CVVH/CVVHD/CVVHDF). This indicator is not applicable to a patient with  
longstanding chronic renal failure receiving routine intermittent hemodialysis.  
Chronic Renal Failure *  It is difficult distinguishing between persistent acute renal failure and end-stage kidney  





Please note the following indicators/conditions in this section:  
 
Indicator Description 
Major Blood Transfusion**  Major blood transfusion is defined as replacement of the total blood volume within 24  
hours.  The formula is found on the last page of the form.  
Major blood transfusion includes all blood products. 
Autotransfusion* Patient receiving autotransfusion should at least be in HICU, due to high risk. 
Post-operative monitoring* 24 - 48 Note that there is no provision made for ECG monitor, because this is a standard 
hours procedure.  This indicator is for patients that require more intense post operative 
monitoring than provided by wards.  E.g. Knee Replacement. 
Cont. Invasive/Non-invasive monitoring Due to the difficulty defining the term Hemodynamic Instability, this indicator basically 
> 4hrs every 15-30 minutes** replace this term.  The indicator implies that the patient is unstable and would include 
Hemodynamic Unstable patients.  This does not include Post-operative monitoring (as 
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Medication IVI  
Note that the IVI Medication Key at the back of the form serves as a guideline as to which types of medication falls within a specific 
indicator.  This is ONLY applicable to IVI Medication.  Medication indicated with ** are CCU drugs and the patients status remains 
CCU for up to 6 hours post discontinuation of these drugs.  
Please note the following indicators/conditions in this section:  
 
Indicator Description 
Positive inotropic support **  Inotropic drugs increase the contractility of the heart and are often required in cardiac  
failure, septic shock or post surgery.  The list of drugs is named in the table of  
intravenous medication.  
 
 
Vasopressors **  Vasopressors increase the systemic vascular resistance and are used in conditions where  
there is vasodilatation and vasoconstriction is required to improve the blood pressure. 
The use of small amounts of adrenaline in an epidural infusion does not count as  
„Vasopressors‟ as the effect is localised.  
Insulin*  It is recommended that critically ill patients have their blood glucose narrowly controlled  
to improve outcomes (the margin varies depending on disease).  Blood glucose is 
elevated as part of the stress response.  
Sedation**  Drugs that have the ability to suppress a patients breathing and ability to protect their  
own airway.  
TPN  It is extremely important that case management is informed when TPN is administrated,  
in order for accounts to be changed accordingly.  
Examples of TPN include; Isotec, Intralipid and Vamin. 
Opioid*  Refers only to opioid analgesia (not all intravenous analgesia, e.g. Perfalgan).  The route  
of administration can be as patient-controlled analgesia (PCA), via an epidural catheter or 
intravenously (whether intermittently or continuously) or intramuscularly. Opioids can 
cause opioid-induced sedation and respiratory depression.  
Precedex®* See addendum A for MCSA Policy regarding administration of this drug. 
Abnormal high levels of therapeutic This refers to abnormally high drug levels of medication administered for therapeutic 
medication ** reasons - examples include high drug levels of digoxin or amikacin.  This does not refer 




Laboratory Imbalances  
Please note the following indicators/conditions in this section:  
 
Indicator Description 
Positive DIC screen **  This indicates that the patient is in Haematology failure.  DIC screen includes INR, aPTT,  
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Monitoring / Invasive Lines  
Please note the following indicators/conditions in this section:  
 
Indicator Description 
ICP monitor 1st 24 hours*** For the first 24 hours post insertion the patient is in SICU. 
ICP monitor > 24 hours** After the 1st 24 hours, as long as the ICP monitor is in situ, the patient is in ICU. 
Central venous O₂ saturation *  A normal SVcvO₂ is > 70%.  The value is decreased if there is decreased tissue perfusion,  




Emergency Procedures  




IV Medication with **  
Please note that IVI medication marked with ** are indicated as CCU patients.  The patient remains CCU for up to 6 hrs post 




Additional Diagnostic Information  
Any comment that could add to the background of the patient‟s clinical condition can be indicated in this section.  Be sure to indicate 
the date of the comment.  This section is also used if the required LOC could not be explained throughout the criteria.  It is also  
suitable for indicating a planned procedure, planned discharge and any other relevant information not mentioned in the rest of the 
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Completing the Form  
The method/procedure of completing the form will be explained by means of a scenario.  
Scenario:  A patient was transferred to a specialised unit the previous day, e.g. 6 July 2011 at 11:30  
Today, 7 July 2011, you have to complete the Clinical Criteria for Specialised Units form according the patient‟s condition the last 24  
hours.  
 
Step Action Note 
1 Stick a patient sticker onto the form in the space provided (top left-hand 
corner) 
2 Write the diagnosis of the patient onto the form in the space provided (top 
right-hand corner) 
3 Write today‟s date (e.g. 7 July 2010) in the first date column of the first 
section you want to complete. 
4 Read through all the indicators/condition in that specific section and tick off 
that which is relevant to the patient. 
5 Repeat steps 3 and 4 for all the applicable sections. 
6 After ticking off all the applicable conditions, check the keys for each E.g.  If a box (indicator/condition) 
marked 
indicator/condition (i.e. *, **, ***) and interpret it according to the key-table with *** is ticked off, the patient should 
on the form. be in SICU,  if 3 ticks were made in 
boxes 
that are not marked with *,** or ***, the 
patient should be in HIC, etc. 7 Complete / update the Patient Status section. 
8 The completed form must be sent to the Unit Manager. 
9 After the form is evaluated and found to be accurate and complete, it must 
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(Addendum to the Clinical Criteria Form) 
  
Position paper of MCSA and The South African Society of Anaesthesiologist.  
_______________________________________________________________________________________________________  
 
Dexmedetomidine (Precedex) Position Paper  
 
Description  
Dexmedetomidine hydrochloride (trade name Precedex) is a selective alpha 2 adrenoreceptor agonist  
with a central mechanism of action, and is used intravenously for its sedative, analgesic and anxiolytic  
effects.  
Dexmedetomidine can cause a significant reduction in blood pressure and pulse rate, and has to be 
administered only under monitored conditions.  
 
Registered uses (package inserts)  
Precedex is a relatively selective alpha2-adrenergic agonist indicated for:  
•    Sedation of initially intubated and mechanically ventilated patients during treatment in an intensive  
 care setting. Administer Precedex by continuous infusion not to exceed 24 hours.  
•    Sedation of non-intubated patients prior to and/or during surgical and other procedures.  
 
Dosage and Administration  
Dosing Guidelines  
•    Precedex dosing should be individualized and titrated to desired clinical response.  
•    Precedex is not indicated for infusions lasting longer than 24 hours  
•    Precedex should be administered using a controlled infusion device.  
•    The terminal elimination half-life (t1/2) of dexmedetomidine is approximately 2 hours and clearance  
 is estimated to be approximately 39 L/h.  
 
Monitoring  
•    Continuously monitor patients while receiving Precedex.  
 
Overview  
Given its original registered uses, dexmedetomidine was included in the Medi-Clinic ICU criteria, which 
impacted on the billing of ICU. Extension of indications and clinical application of the drug in other 
situations (even in general wards) causing conflict in terms of billing as well as the safety of clinical 
practices forced us to re-evaluate the situation.  
 
A Precedex utilisation study at Medi-Clinic showed a steep upward trend, and that it was used in cases  
not receiving specialized care and sometimes in general wards as well. Although dexmedetomidine  
might now be seen as a safe and effective therapeutic agent in the management of a wide range of  
clinical conditions it was made very clear by both the distributing pharmaceutical company (Abbott  
Laboratories) as well as an updated policy statement (21 October 2009) from SASA that the drug MUST  
be used according to labelled instructions and that “the South African Society of Anaesthesiologists thus  
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Medi-Clinic‟s position  
•    All previous policies and decisions on dexmedetomidine (Precedex) are cancelled.  
•    Dexmedetomidine (Precedex) is included into the ICU criteria at a minimum level of high care.  
•    Dexmedetomidine may be used, according to indications, in any setting where the patient can be  
 monitored to the minimum level of a high care setting.  




Hannes Loots  
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THE SOUTH AFRICAN SOCIETY OF ANAESTHESIOLOGISTS  
         
(Official group of SAMA)  
Association incorporated under Section 21 
Reg. No. 1927/000136/08  
VAT No. 4680223379  
 
P O Box 1105  
CRAMERVIEW  
 2060  
Telephone : 011 463 0684  
Telefax : 011 463 1041 
Email :  sasa@uiplay.com 
21 October 2009  
The Product manager: Dexmedetomidine  (Precedex) 
Abbott Laboratories  
 
Dear Sir,  
 
Thank you for your enquiry concerning the use of dexmedetomidine in a general ward  
setting. This matter was referred to the members of the Council of the South African Society  
of Anaesthesiologists as well as to the members of the Education Business unit for  
consideration.  
 
The literature was extensively reviewed including the Cochrane Library, NICE, and the 
Bandolier   site.   There   is   absolutely   no   data   to   support   the   practice   of using 
dexmedetomidine in a general ward setting. All data suggests that this agent is capable of 
causing severe blood pressure depression as well as deep sedation. This implies that the 
use of dexmedetomidine does require constant monitoring.  
 
We are all aware of the standard of nursing care in a general ward and thus constant 
monitoring by nursing personnel is not feasible. Furthermore there are not enough monitors 
available for use in general wards. The obvious implication of this situation is that patients 
who are on dexmedetomidine infusions in a general ward may not be adequately monitored 
and as such this may present as a potential medico-legal hazard.  
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The South African Society of Anaesthesiologists thus cannot recommend or condone  the 
use of dexmedetomidine in a general ward setting.  
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APACHE IV® SCORE  
 
Report on worst values obtained in first 24 hours of admission to your unit 
Completion of all fields are mandatory  
GENERAL PATIENT INFORMATION   




Admission Date & Time to Hospital 20 / / hh : mm 
Admission Date & Time to CCU 20 / / hh : mm 
Date of Birth / / 






Chronic Health Status 
None / Other Leukaemia / Multiple Myeloma 
AIDS Immunosuppression 
Hepatic Failure Cirrhosis 
Non-Hodgkin‟s Lymphoma HIV Positive / ARV Treatment 
Solid Tumor with Metastases Diabetes Mellitus 
 
CCU Admission 
Admit from nursing unit in your hospital Admit from another hospital 
Admit from operating room Admit from emergency centre 
Operative Patient Yes  /   No 
Emergency Surgery Yes  /   No 
Readmission to Unit Yes  /   No Answer yes if admit from non Apache unit to your unit 
PATIENT PHYSIOLOGY INDICATORS  
Pulse 
Heart rate furthest from 75 bpm 
 
bpm Glucose 















furthest from 38°C 
 
°C Hematocrit 





Core Body Temperature 
Indicate Yes if above temperature is 




No White Blood Count 


























furthest from 19 breaths/min 
 
breaths/min Creatinine 






© COPYRIGHT MEDICLINIC CCU = Critical Care Unit 
bpm = beats per minute 
dcprinters.co.za 


























PATIENT PHYSIOLOGY INDICATORS   






PaO2 of worst blood gas 
 
n.a kPa mmHg 
Sodium 





PaCO2 of worst blood gas 
 
n.a kPa mmHg 
Albumin 






















GLASGOW COMA SCALE  
If patient is ventilated but not sedated / paralysed / anaesthetised obtain the worst score in 24 hour time period. 
Note the different verbal section for ventilated patients that are not sedated / paralysed / anaesthetised.  
 
EYES VERBAL NOT VENTILATED MOTOR 
Open Spontaneously Orientated Obeys Commands 
Open to Speech Confused Localizes Pain 
Open to Pain Innappropriate Words Withdraws from Pain 
No Eye Opening Incomprehensible Sounds Flexion to Pain 
 No Verbal Response Extension to Pain 
 
VERBAL: VENTILATED BUT NOT SEDATED No Motor Response 
 Orientated  
 Confused  
 No Verbal Response  
 
Admission Diagnosis  
 
If a CABG was done complete the following fields: 
Ejection Fraction 
 
Medication Dependant Diabetes Yes / No 
Was Internal Mammary Artery (IMA) used Yes / No 
Myocardial Infarction during Hospitalisation Yes / No 
Redo CABG Yes / No 
Number of Grafts 
 
 
If Diagnosis of Acute Myocardial Infarction then indicate if Thrombolytic Therapy was given Yes / No 
 
DISCHARGE INFORMATION  
Discharge Date & Time from CCU 20 / / hh : mm 
Status on Discharge from Unit Alive Deceased 
  
Other Acute Care Facility 
 
Natural Causes 









Data Collector Signature: Date: 
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Addendum D  
Medi-Clinic Case Mix Methodology  
Author:  Mr Jannie van Schalkwyk 
 
Introduction  
Case mix refers to the characteristics of patients served by a health service provider,  
where  some  patients  are  at  greater  risk  of  having  less  successful  treatment  
outcomes than other patients. Health service providers have no control over these  
characteristic and therefore the need exist to keep them fixed in comparative  
analysis. The ability to measure heterogeneous case mix of hospitals has been  
recognized for some time as a critical ingredient for improving the management of  
hospitals and health systems through planning and quality assurance, as well as  
achieving equity in hospital reimbursement. Without the capability to measure case- 
mix differences, the comparative analysis of hospital outcomes and attempts to  
establish the reasonableness of those outcomes often reflect in oversimplification of  
the issues involved and may result in spurious and misleading findings.  
 
History  
The case mix concept has been introduced in the USA more than twenty-five years 
ago in order to measure hospital productivity and to promote quality of care. The 
DRGs (Diagnosis Related Groupings), developed by a team of researchers led by 
Robert Fetter and John Thompson at Yale University, were selected by HCFA (Health 
Care Financing System) in 1983 as the case mix classification system for the 
MEDICARE prospective payment system (PPS).  
 
The DRG was the first “health management tool” to group patients in clinically 
meaningful categories with homogeneous resources consumption. All diagnostic 
categories and procedures based on medical record summaries could be coupled 
with  financial  data  about  resource  uses,  for  individual  patients,  in  order  to 
differentiate high and low cost care. Even if shortcomings were underlined since 
their beginning, DRGs are still used in the USA as the main tool for case based, 
clinical encounter focused, payment.  
Many other countries have adopted the case mix concept after long periods of  
testing and accepting, but with large variations in data collection, information  
standards, grouping tools, financing methods and quality of care developments all  
over the world. Each country has developed a local clinical and political culture about  
case mix tools. Case mix development in South Africa is being driven by the private  
health sector for their own use, namely to improve the standard of clinical data used  
in interactions  in  the  industry.  These include  a  range  of  financial uses  from  
information system creation, budget setting and contracting around alternative  
reimbursement models. The CMS (Council of Medical Schemes) are developing an  
awareness of its value within the sector. However, this is a recent development and  
previous attempts by 3M and by a handful of university and parastatal based  
academics did not achieve sufficient impetus.  
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Analytical Approach  
Medi-Clinic is under increasing financial pressure to improve outcomes with fewer  
resources available. Therefore the need exists to evaluate units in our business in a  
justifiable manner (controlling differences in characteristics of patients treated in  
each unit) in order to focus resources in the right areas. We therefore evaluated the  
DRG system to address case-mix differences in our units. The system is designed to  
produce groups of patients homogeneous with respect to some measure of resource  
use (LOS or cost) and is undoubtedly one of the best-known methods of patient  
classification,  but  limitedly  takes  into  account  severity  of  illness  by  including  
indicator variables for the presence and absence of surgery and in some versions  
comorbidities. Furthermore DRG is based on the principal that diagnosis drives cost  
in contradiction with our faith that costs are driven mainly by procedure or  
treatment.  
 
We believe that a lot of detail about the type and severity of a patient which is both  
meaningful and readily available comes from the codes on the discharge summary.  
However, the number of possible codes is too large to handle without collapsing  
them into groupings. We therefore have adapted the CCRG (Clinical and Cost Related  
Groupings) which is a unique in-house system of mutually exclusive groupings of  
CPT-4 (Current   Procedural   Terminology),   ICD-10 (International   Statistical  
Classification of Diseases) and SADA (South African Dental Assocation) codes into a  
hierarchical structure of subgroups, groups and categories. We also implemented a  
computer algorithm deciding which codes explain the outcome the best.  
We developed the HRM (Hospital Risk Model) which entails a generic method that  
permits the actual outcome (costs, length of stay, mortality- and other quality  
outcomes) to be compared to statistically modelled “expectations”, given the mix of  
patients at a level.  The method will statistically account for the number, mix and  
severity of cases because outcome variables are dependent on these factors. The  
model further provides breakdown analysis to quantify the magnitude of impact and  
interactions of these variables to assist in making more informed decisions.  
The basic strategy employs the specification of a mathematical equation describing  
the outcome of interest as a function of a set of explanatory variables by means of  
OLS (ordinary least squares), GLM (generalized linear models), logistic or multinomial  
stepwise regression techniques. The explanatory variables describe characteristics of  
a case that are expected to affect the outcome (such as the clinical condition for  
which was rendered, the presence of other conditions that could complicate the stay  
and the patient’s profile). These equations are estimated, that is, numerical values  
are computed for the parameters of the function that describes the impact of each  
“explanatory variable” on the outcome variable.  Case mix can then be accounted for  
by computing the value of this function, using these estimated parameters, for the  
data values representing the specific characteristics. The result of this process is an  
expected value that is a mathematical function of a hospital’s case mix, severity and  
demographic profile of the patients.  For example, a hospital that treats more  
 
 






severely ill, elderly people will be expected to have higher costs than a hospital that 
treats a generally healthy and young population for a similar set of procedures.  
Although calculations can be complex, interpreting the output is relative easy to do.  
The model makes use of the index methodology to describe the magnitude and  
importance of differences. It is convenient to group explanatory (characteristic)  
variables to belong to one of two mutually exclusive groups: those which are  
demographic or contribute to the disease status or degree of illness of the patient  
(patient-level factors) and those which represent the hospital environment or  
determined  how  a  patient  is  cared for from  hospital  admission  to  discharge  
(hospital-level factors).  The underlying strategy is to divide the actual observed  
outcome by the predicted outcome on the basis of patient-level factors. This result,  
defined as the index, provides information about the percentage deviation from the  
expected. If the index is greater than 1 the patient has had a higher outcome than  
expected; if negative, the outcome was lower than expected. Random variation  
might explain part of any such discrepancy in an individual patient. However, if the  
overall index is significantly greater than 1, this presumably reflects hospital-level  
factors which tend to lead to a negative outcome. Similarly an overall index  
significantly less than 1 will reflect hospital-level factors that tend to lead to positive  
outcomes. In order to determine significance of cut-off levels we apply parametric or  
non-parametric statistical control limits, depending on the type of situation, to  
determine  acceptance  and  rejection  regions.  Figure 1 below illustrates the  
application of the index methodology for hospitals.  
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Model Validation  
The question will arise to exactly what extent and how accurate the model describes  
risk in reality. We realise that model validation are essential parts of the model  
development process if the model are to be accepted for decision making, so not  
only do we strive to design our coding and grouping systems to accurately reflect  
reality, we also make use of statistical and model designing techniques to validate  
the model. Often the validation of a model seems to consist of nothing more than 
quoting the coefficient of correlation 2 R statistic (statistical measure that represents 
2  
how well the model approximates real data points).  Unfortunately, a high  R  values  
does not guarantee that the model will describe reality well. In order to address this  
issue we have designed the model building process to remove random effects, hence  

















































Significant Variables  
 
The process basically entails the selection of two random samples from the original  
dataset. All risk variables defined are fitted through random sample 1 to come up  
with a list of significant variables. These variables are then fitted on the second  
random sample in order to remove random significant variables identified in the first  
phase. These variables are then fitted on the full dataset to calculate the final model  
parameters. The model is then fitted on an independent sample and actual values  
compared to statistical modelled expectations. If the modelled values do not closely  
describes the actual outcomes, model parameters are re-evaluated iteratively until a  
satisfactory level of accuracy is reached.  
 
Trends & Analysis  
Another application of the capability to measure case-mix differences is the ability to  
do comparative analysis over time. We would like to share some of the interesting  
trends we have identified with the reader. It is important to note that in order to do  
this type of analysis one needs to look at all patient-level factors to get the full  
picture of patient risk in order making the right interpretations. Also it is important  
to note that the trends are for Medi-Clinic in general and will not necessary be the  
 






same for different components of the business.  Medical insurance legislation 
changes for example can cause trend changes for the insured population that will 
not necessarily impact the private population.  
 
Figure 3 indicates a decline in patient-level risk over time. The four lines on the figure  
represent four different models based on four different years. The spread between  
these lines will be representative of inflation differences. It is worthy to note that the  
four models are consistently showing the same seasonal trends, which is an  
indicating of accurate and reliable model results. Why are we experiencing this  
trend, while at the same time we see our population is ageing over time as  
illustrated in Figure 3?  
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3 4 5 
6 7 
8 9  10 
11  12 
 1 2 3 4 5 6 7 8 9 10 11 12  
2004 39.4 39.5 39.1 38.8 38.5 38.3 38.2 38.3 38.2 38.3 38.5 38.4 
2005 39.6 39.6 39.2 39.0 38.9 38.6 38.5 38.6 38.6 38.7 38.8 38.8 
2006 40.2 39.9 39.5 39.1 38.9 38.7 38.6 38.8 38.7 38.9 39.0 39.0 
2007 40.3 40.2 39.7 39.3 39.2 39.0 39.0 39.0 39.0 39.1 39.2 39.2 
 






To explain this we have done a breakdown to understand which patient-level factors  
are causing the declining trend. We have decided to exclude outpatient cases, since  
emergency, wound care clinics and other outpatient units have grown considerable  
over time, hence impacting on the overall case-mix outcome.  Also from an  
administrative point of view, more emergency-admission accounts are now split- 
billed that were previously billed as one account. This digress the number of cases  
and cause a diluted decrease of patient risk over time. Therefore we concentrated  
only on cases with theatre time or accommodation for the purpose of the analysis.  
Figure 4 illustrates the change in some of the different components of patient level  
risk namely age, gender, surgical- and medical-mix in general.  
 
Figure 4 - Overall Risk Breakdown Comparison 
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Surgical Mix Risk 
Linear (PMB Risk) 


















The first thing to note from Figure 4 is that the overall risk (green line) is still  
declining with the outpatient cases removed from the analysis. It is apparent from  
the graph that although the ageing of the population had a positive impact on the  
risk change,  the  overall  risk  change  was 
dominated   by   decreasing   surgical-   and  
medical-mix   changes   indicated   by   the  
negative slopes of the respective trend lines.  
The medical risk change tends to dominate  
the impact on the overall risk over time. This  
is most probable caused by the increase in the  
portion of medical cases relative to surgical  
ones as illustrated in Figure 5. Interpreting 
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this trend in combination with the decrease in medical risk, it can be an indication  
that the growth in medical cases is supplemented by an increase in low risk cases.  
Figure 4 also shows a decline in the surgical risk of patients. We needed to have a  
better understanding of this, since it is not only contradictive to the ageing and  
increasing average theatre time of the population, but also in important from an  
operational point of view. We investigated the relation between age, gender and  
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The solid and dotted lines represents surgical risk within each age category for 2004  
and 2007 for females and males respectively and the spread will reflect the  
differences in surgical risk. The green bars indicate the change in specific age  
categories between the respective years. Positive values will be an indication of  
positive growth within the specific age category between years; similarly a negative  
value will indicate drops. Having a closer look at age categories B11-B15, clearly  
indicating growth in the older age categories, we see a drop in surgical-mix for the  
same categories as indicated by the spread difference. We can thus conclude that  
the change in surgical-mix outweighed the age risk change resulting in an overall  
declining surgical risk. In an attempt to understand the change in surgical mix we  
have done a further in depth analysis looking at the surgical procedures that are  
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Procedure Risk Category Annual Change 
Mitral valvuloplasty replacements High -6.490% 
Aorta valvuloplasty replacements High -0.930% 
Gastrectomy High -5.320% 
CABG High -3.280% 
Ophthalmological surgery Low 10.080% 
Plastic & Reconstructive surgery Low 5.370% 
Obstetrics and gynaecology Low 7.420% 
Minor Uro Genital surgeries Low 6.970% 
 
We conclude that the drop in surgical mix was caused by some high risk procedures,  
but to a greater extend by an increase in a high number of low risk procedures. This  
fact together with the decrease in medical mix is the main drivers for a declining  
overall patient risk. Understanding the components of patient level risk is complex  
because of the intricate relation that exists between factors and therefore it is  




This analysis demonstrates the feasibility to have a case-mix adjustment system,  
using existing administrative data. The multivariate models used also shows that  
certain patient-level characteristics could explain variations in risk. However, for a  
variety of technical reasons, the detailed results from these models should be  































Mortality as a quality outcome?  
Healthcare providers have always been concerned about patient outcomes and  
evaluating outcomes as a means of determining the effectiveness of care. Much of  
the philosophical basis for outcomes measurement is derived from the early work of  
Florence Nightingale. Nightingale used mortality statistics to portray the low quality  
of care provided to British soldiers during the Crimean War. It has been said that  
Nightingale was the first person to use diagrams for presenting statistical data.  
Although this is most probable not true, she may have been the first to use them for  
persuading people for the need for change.  Her methods indeed succeeded by  
reducing mortality from 60% at her arrival to 2% six months later.  
That fact that patients die in hospitals every day is both an accepted fact of hospital  
care delivery and a reflection of avoidable hospital inefficiencies. These inefficiencies  
are  subject  to  control  and  include  poor  infection  control,  inadequate  or  
inappropriate  use  of  medication,  falls  as  a  result  of  poor  supervision  or  
understaffing, mistakes during surgery, and inappropriate level of care. Some,  
perhaps many, of these deaths might be prevented if all the factors that contribute  
to them are better understood. A study, for example, looking at the association  
between patient-to-nurse ratio and patient mortality concluded that, after adjusting  
for patient and hospital characteristics (size, teaching status, and technology), each  
additional patient per nurse was associated with a 7% (odds ratio, 1.07; 95%  
confidence interval, 1.03-1.12) increase in the likelihood of dying within 30 days of  
admission. Surely hospitals do not have control over worsening nursing shortages  
and legislation changes, but can use this information to address problem areas and  
optimally plan resources. The adjusted ratios should be seen as a kind of red flag for  
performance improvement and not a verdict.  
As in most improvement efforts the process should start with measuring outcomes. 
It has been stressed in the case-mix article that these types of comparisons have 
little meaning unless adjustments are made for patient risk differences. One could 
thus conclude that hospital mortality rate, appropriately adjusted for patient risk 




Methodology Used  
 
We have developed a statistical methodology to adjust hospital mortality rates for 
patient level risk factors in order to make justifiable comparisons between hospitals. 
We also expanded this methodology to measure trends over time.  
We treated deaths as a binary response variable and used a logistic regression model  
to measure the relation with patient risk variables in order to adjust for case-mix  
 
 




eβ +β  
differences.  The outcome is an expected value per admission reflecting the 
probability that the admission will result in a death. 
0 1 1x + β 2 
x2 
E(y) = 




1+e β  +β 0 1 
1x + β 2 x2 + + β k x k 
where 0 Survived  
 
E(y)=π  =P(Deceased) 
 
The coefficient ˆ in the logistic model estimates the change in the log-odds if x is 
i i 
increased by 1 unit, holding all other x's  in the model fixed. Therefore the model 
can also produce an estimated increase in risk for each of the various risk variables. 
For example a patient odds of dying in hospital, treated for an Infectious or Parasitic 
disease, will increase with a factor of 1.17. More specifically, a patient treated for 
Tuberculosis, will have a 2.12 increase in the odds factor of dying in hospital.  The 
difference in magnitude between the coefficients of these risk variables are a 
reflection of the dependence with the outcome variable.  
 
 
Trends & Analysis  
The chart below is an illustration of mortality outcome of Medi-Clinic hospitals using  
statistical control charts. The horizontal axis represents volume and the vertical axis  
mortality rate. The curve lines are the control limits defined as 90%, 95%, and 99%  
confidence intervals with the purpose to identify units whose performance diverse  
significantly from the norm. The green dots represent crude mortality and the red  
dots risk adjusted mortality. The solid green and red line is the chronological  
accumulative mortality outcome of a single Medi-Clinic hospital, known to treat high  
risk cardiac cases, for crude and risk adjusted mortality respectively. The spread  
increase rapidly because of the high risk nature of these patients and the crude  
mortality are quickly out of control. The risk adjusted mortality stays within control,  
indicating that although the crude mortality is significantly higher then the norm; it is  
mainly contributable to patient level risk and not a reflection of inefficient hospital  
processes.  
The idea is to measure this on continues basis and flag hospitals as soon as the  
outcome (mortality rate) is out of control. Doing this will ensure that high mortality  
rates, contributable to inefficient hospital processes, are proactively identified and  
managed, rather than a retrospective review at the end of the financial period.  
Understanding the issues involved will assist to design processes to prevent possible  





















































































































































Hospital History  
0  
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Like mentioned earlier it is also possible to do trend comparisons over time. The  
graph below illustrates crude and expected morality for Medi-Clinic for 2004 to  
2007. It is important to note that although the crude mortality rate is increasing, the  









Modelled Risk  
































The reason for this increase can be explained by a change in various risk factors, but 
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(1) Ageing of the population. Figure 1 shows that there is an exponential relation 
between mortality risk and age, apart from neonatal cases. Figure 2 shows that our 
population is ageing, hence one could conclude that our mortality risk is increasing 
due to an increase in age of the population.  
    
Figure 1 - Age vs Expected Mortality Figure 2 - Medi-Clinic Inpatient Population Ageing Avg Age 


















(2) Increase in the proportion of medical cases relative to surgical ones as illustrated  
in Figure 4. Figure 3 shows that mortality risk for medical cases are higher then for  
surgical ones, hence one could conclude that this is another reason for the increase. 
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(3) Increase in HIV related cases. Legislation and patient confidentially does not allow 
information around HIV cases to be captured, hence we needed to use clinical 
criteria to identify certain procedures that can be used as a proxy for HIV cases. 
Figure 5 shows that HIV-related cases have a higher mortality risk then the rest. 
Figure 6 shows a growth in the portion of HIV-related cases relative to the rest, 
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The Human Research Ethics Committee granting this approval is in compliance with the IOi Harmonised Tripartite 
Guidelines E6: Note for Guidance on Good Oinical Practice (CPMP/ICH/ 135/95) and FDA Code Federal Regulation 
Part 50, 56 and 312. 
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See 'About this journal' for descriptions of different article types and information about  
policies and the refereeing process.  
Submission process  
Manuscripts must be submitted by one of the authors of the manuscript, and should not be 
submitted by anyone on their behalf. The submitting author takes responsibility for the 
article during submission and peer review.  
Please note that all content published in Critical Care is entirely open access. Critical Care  
levies an article-processing charge on all accepted Research Articles that have not been  
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online submission.  
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manuscript should be published in the journal, to elaborate on any issues relating to our  
editorial policies in the 'About Critical Care' page, and to declare any potential competing  
interests. You will be also asked to provide the contact details (including email addresses) of  
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past five years, should not be current collaborators, and should not be members of the  
same research institution. Suggested reviewers will be considered alongside potential  
reviewers recommended by the Editor-in-Chief and/or Editorial Board members.  
 
Assistance with the process of manuscript preparation and submission is available from  
BioMed Central customer support team. 
We also provide a collection of links to useful tools and resources for scientific authors on  
our Useful Tools page.  
File formats  
The following word processor file formats are acceptable for the main manuscript 
document:  
 
•     Microsoft word (DOC, DOCX)  
•     WordPerfect (version 5 and above)  
•     Rich text format (RTF)  
•     Portable document format (PDF)  
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TeX format. During the TeX submission process, please submit your TeX file as the main  
manuscript file and your bib/bbl file as a dependent file. Please also convert your TeX file  
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will be used by internal staff as a reference point to check the layout of the article as the  
author intended. Please also note that all figures must be coded at the end of the TeX file  
and not inline.  
If you have used another template for your manuscript, or if you do not wish to use BibTeX,  
then please submit your manuscript as a DVI file. We do not recommend converting to RTF.  
 
For all TeX submissions, all relevant editable source must be submitted during the  
submission process. Failing to submit these source files will cause unnecessary delays in the 
publication procedures.  
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ISRCTN73824458). Please note that there should be no space between the letters and  
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see also our guide for writing an easily accessible abstract.  
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participants or materials involved, a clear description of all interventions and comparisons, 
and the type of analysis used, including a power calculation if appropriate. Generic drug 
names should generally be used. When proprietary brands are used in research, include the 
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Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. In: Bourne GH,  
Danielli JF, Jeon KW, editors. International review of cytology. London: Academic; 1980. p.  
251-306.  
 
OnlineFirst chapter in a series (without a volume designation but with a DOI)  
Saito Y, Hyuga H. Rate equation approaches to amplification of enantiomeric excess and 
chiral symmetry breaking. Top Curr Chem. 2007. doi:10.1007/128_2006_108.  
 
Complete book, authored  
Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of 
common illness. 3rd ed. Oxford: Blackwell Science; 1998.  
 
Online document  
Doe J. Title of subordinate document. In: The dictionary of substances and their effects.  
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Royal Society of Chemistry. 1999. http://www.rsc.org/dose/title of subordinate document.  
Accessed 15 Jan 1999.  
Online database  
Healthwise Knowledgebase. US Pharmacopeia, Rockville. 1998. http://www.healthwise.org.  
Accessed 21 Sept 1998.  
 
Supplementary material/private homepage  
Doe J. Title of supplementary material. 2000. http://www.privatehomepage.com. Accessed  
22 Feb 2000.  
 
University site  
Doe, J: Title of preprint. http://www.uni-heidelberg.de/mydata.html (1999). Accessed 25  
Dec 1999.  
 
FTP site  
Doe, J: Trivial HTTP, RFC2169. ftp://ftp.isi.edu/in-notes/rfc2169.txt (1999). Accessed 12 Nov  
1999.  
 
Organization site  
ISSN International Centre: The ISSN register. http://www.issn.org (2006). Accessed 20 Feb  
2007.  
Preparing illustrations and figures  
Illustrations should be provided as separate files, not embedded in the text file. Each figure  
should include a single illustration and should fit on a single page in portrait format. If a  
figure consists of separate parts, it is important that a single composite illustration file be  
submitted which contains all parts of the figure. There is no charge for the use of color  
figures.  
Please read our figure preparation guidelines for detailed instructions on maximising the  
quality of your figures.  
Formats  
 
The following file formats can be accepted:  
 
•     PDF (preferred format for diagrams)  
•     DOCX/DOC (single page only)  
•     PPTX/PPT (single slide only)  
•     EPS  
•     PNG (preferred format for photos or images)  
•     TIFF  
•     JPEG  
•     BMP  
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Critical Care will edit all figures supplied by the author. For this reason it is especially  
important that authors should supply figures in vector form, to facilitate such editing.  
Figure legends  
The legends should be included in the main manuscript text file at the end of the document, 
rather than being a part of the figure file. For each figure, the following information should be 
provided: Figure number (in sequence, using Arabic numerals - i.e. Figure 1, 2, 3 etc); short 
title of figure (maximum 15 words); detailed legend, up to 300 words.  
Please note that it is the responsibility of the author(s) to obtain permission from the  
copyright holder to reproduce figures or tables that have previously been published  
elsewhere.  
Preparing tables  
 
Each table should be numbered and cited in sequence using Arabic numerals (i.e. Table 1, 2,  
3 etc.). Tables should also have a title (above the table) that summarizes the whole table; it 
should be no longer than 15 words. Detailed legends may then follow, but they should be 
concise. Tables should always be cited in text in consecutive numerical order.  
Smaller tables considered to be integral to the manuscript can be pasted into the end of the  
document text file, in A4 portrait or landscape format. These will be typeset and displayed  
in the final published form of the article. Such tables should be formatted using the 'Table  
object' in a word processing program to ensure that columns of data are kept aligned when  
the file is sent electronically for review; this will not always be the case if columns are  
generated by simply using tabs to separate text. Columns and rows of data should be made  
visibly distinct by ensuring that the borders of each cell display as black lines. Commas  
should not be used to indicate numerical values. Color and shading may not be used; parts  
of the table can be highlighted using symbols or bold text, the meaning of which should be  
explained in a table legend. Tables should not be embedded as figures or spreadsheet files.  
 
Larger datasets or tables too wide for a landscape page can be uploaded separately as  
additional files. Additional files will not be displayed in the final, laid-out PDF of the article, 
but a link will be provided to the files as supplied by the author.  
Tabular data provided as additional files can be uploaded as an Excel spreadsheet (.xls ) or  
comma separated values (.csv). As with all files, please use the standard file extensions.  
Preparing additional files  
 
Although Critical Care does not restrict the length and quantity of data included in an article,  
we encourage authors to provide datasets, tables, movies, or other information as  
additional files.  
 
Please note: All Additional files will be published along with the article. Do not include files  
such as patient consent forms, certificates of language editing, or revised versions of the  
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main manuscript document with tracked changes. Such files should be sent by email to  
editorial@ccforum.com, quoting the Manuscript ID number.  
Results that would otherwise be indicated as "data not shown" can and should be included  
as additional files. Since many weblinks and URLs rapidly become broken, Critical Care  
requires that supporting data are included as additional files, or deposited in a recognized  
repository. Please do not link to data on a personal/departmental website. The maximum  
file size for additional files is 20 MB each, and files will be virus-scanned on submission.  
 
Additional files can be in any format, and will be downloadable from the final published 
article as supplied by the author.  
Certain supported files formats are recognized and can be displayed to the user in the 
browser. These include most movie formats (for users with the Quicktime plugin), 
miniwebsites prepared according to our guidelines, chemical structure files (MOL, PDB), 
geographic data files (KML).  
If additional material is provided, please list the following information in a separate section 
of the manuscript text:  
 
•     File name (e.g. Additional file 1)  
•     File format including the correct file extension for example .pdf, .xls, .txt, .pptx  
 (including name and a URL of an appropriate viewer if format is unusual)  
•     Title of data  
•     Description of data  
 
Additional files should be named "Additional file 1" and so on and should be referenced  
explicitly by file name within the body of the article, e.g. 'An additional movie file shows this 
in more detail [see Additional file 1]'.  
Additional file formats  
Ideally, file formats for additional files should not be platform-specific, and should be  
viewable using free or widely available tools. The following are examples of suitable  
formats.  
 
•     Additional documentation  
o   PDF (Adode Acrobat)  
•     Animations  
o   SWF (Shockwave Flash)  
•     Movies  
o   MP4 (MPEG 4)  
o   MOV (Quicktime)  
•     Tabular data  
o   XLS, XLSX (Excel Spreadsheet)  
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As with figure files, files should be given the standard file extensions.  
Mini-websites  
Small self-contained websites can be submitted as additional files, in such a way that they 
will be browsable from within the full text HTML version of the article. In order to do this, 
please follow these instructions:  
 
1.  Create a folder containing a starting file called index.html (or index.htm) in the root.  
2.  Put all files necessary for viewing the mini-website within the folder, or sub-folders.  
3.  Ensure that all links are relative (ie "images/picture.jpg" rather than  
"/images/picture.jpg" or "http://yourdomain.net/images/picture.jpg" or  
"C:\Documents and Settings\username\My Documents\mini- 
website\images\picture.jpg") and no link is longer than 255 characters.  
4.  Access the index.html file and browse around the mini-website, to ensure that the  
 most commonly used browsers (Internet Explorer and Firefox) are able to view all  
 parts of the mini-website without problems, it is ideal to check this on a different  
 machine.  
5.  Compress the folder into a ZIP, check the file size is under 20 MB, ensure that  
index.html is in the root of the ZIP, and that the file has .zip extension, then submit 
as an additional file with your article.  




Currently, Critical Care can only accept manuscripts written in English. Spelling should be US 
English or British English, but not a mixture.  
There is no explicit limit on the length of articles submitted, but authors are encouraged to 
be concise.  
Language editing  
For authors who wish to have the language in their manuscript edited by a native-English  
speaker with scientific expertise, BioMed Central recommends Edanz. BioMed Central has  
arranged a 10% discount to the fee charged to BioMed Central authors by Edanz. Use of an  
editing service is neither a requirement nor a guarantee of acceptance for publication.  
Please contact Edanz directly to make arrangements for editing, and for pricing and  
payment details.  
Help and advice on scientific writing  
The abstract is one of the most important parts of a manuscript. For guidance, please visit  
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Tim Albert has produced for BioMed Central a list of tips for writing a scientific manuscript.  
American Scientist also provides a list of resources for science writing. For more detailed  
guidance on preparing a manuscript and writing in English, please visit the BioMed Central 
author academy.  
Abbreviations  
Abbreviations should be used as sparingly as possible. They should be defined when first  
used and a list of abbreviations can be provided following the main manuscript text.  
Typography  
 
•     Please use double line spacing.  
•     Type the text unjustified, without hyphenating words at line breaks.  
•     Use hard returns only to end headings and paragraphs, not to rearrange lines.  
•     Capitalize only the first word, and proper nouns, in the title.  
•     All pages should be numbered.  
•     Use the Critical Care reference format.  
•     Footnotes are not allowed, but endnotes are permitted.  
•     Please do not format the text in multiple columns.  
•     Greek and other special characters may be included. If you are unable to reproduce a  
 particular special character, please type out the name of the symbol in full. Please  
 ensure that all special characters used are embedded in the text, otherwise they  
 will be lost during conversion to PDF.  
Units  
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